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SUMÁRIO 
 
A isquémia cerebral resulta de um fornecimento insuficiente de sangue 
ao cérebro, levando a uma desregulação no equilíbrio entre a 
neurotransmissão excitatória/inibitória e consequente morte celular por 
excitotoxicidade. A actividade das redes neuronais no sistema nervoso 
central (SNC) é determinada maioritariamente pelo balanço entre a 
neurotransmissão glutamatérgica e GABAérgica, que se encontra 
aumentada e reduzida, respectivamente, nas lesões isquémicas. O papel 
desempenhado pelo glutamato nos danos isquémicos está largamente 
documentado, ao contrário das alterações na neurotransmissão inibitória 
que permanecem pouco estudadas. 
Estudos in vivo e in vitro mostraram uma desregulação da 
neurotransmissão GABAérgica em cérebro isquémicos, ao nível pré- e 
pós-sináptico. A incubação de fatias de hipocampo na ausência de 
oxigénio e glucose (OGD) induz uma libertação rápida de GABA por 
exocitose, seguida de uma fase tardia em que ocorre a libertação do 
neurotransmissor mediada por reversão do transportador da membrana 
plasmática. A diminuição dos transportadores vesiculares do GABA na 
sinapse e a perda de ATP são dois mecanimos que podem estar na origem 
da redução da libertação excitotóxica de GABA. Os receptores de GABA 
do tipo GABAA (GABAAR) são os principais intervenientes na inibição 
sináptica rápida no SNC e a diminuição da sua expressão superficial foi 
demonstrada em modelos de isquémia in vivo e in vitro. A estabilização 
da expressão superficial dos GABAAR foi recentemente correlacionada 
com a protecção de neurónios do hipocampo e do córtex cerebral sujeitos 
a OGD, e o bloqueio da internalização dos GABAAR dependente da 
interacção AP2/clatrina reduz também a morte neuronal causada pela 
OGD. Estas evidências indicam que o número de GABAAR na superfície 
celular e a internalização deste receptor desempenham um papel 
modulador da morte celular causada pela isquémia. Porém, os 
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mecanismos moleculares envolvidos na internalização dos GABAAR não 
foram ainda desvendados. 
Neste trabalho investigámos os mecanismos moleculares envolvidos na 
diminuição dos GABAAR em culturas de hipocampo submetidas OGD, 
um modelo in vitro de isquémia cerebral. A exposição transitória de 
neurónios de hipocampo a OGD fez diminuir os níveis totais das 
subunidades dos receptores GABAA características de receptores 
sinápticos (α1, α2, β3, γ2), por um mecanismo dependente da activação 
de calpaínas, mas não afectou os níveis da subunidade δ, tipicamente 
encontrada em receptores extra-sinápticos. Resultados semelhantes 
foram observados na região de enfarte em murganhos sujeitos à oclusão 
da artéria cerebral média (MCAO). Experiências de PCR quantitativo 
mostraram uma diminuição da expressão das subunidades dos GABAAR 
do tipo α1, α2, β2, β3 e γ2 mediada pela activação dos receptores do 
glutamato. Contudo, a inibição da transcrição não contribuiu para a 
diminuição dos níveis de proteína total das subunidades dos GABAAR. 
A maioria dos GABAAR presentes no cérebro contêm as subunidades 2α, 
2β, e 1γ2, e apresentam uma grande mobilidade entre a localização 
sináptica e extra-sináptica. A acumulação do receptor nas sinapses 
inibitórias é regulada pela gefirina, uma proteína estrutural que permite 
a estabilização dos GABAAR na sinapse. A população de GABAAR da 
superfície neuronal é reciclada continuamente entre a membrana 
plasmática e os compartimentos intracelulares. Os mecanismos de 
regulação da expressão superficial dos GABAAR desempenham um papel 
fundamental no controlo dos níveis de receptor na sinapse e, 
consequentemente, da actividade sináptica inibitória. A internalização 
dos GABAAR é regulada negativamente pela fosforilação das subunidades 
β3 ou γ2 numa sequência intracelular. Em condições fisiológicas normais 
a fosforilação destas subunidades é controlada pela calcineurina, uma 
fosfatase activada pela entrada de Ca2+ através dos receptores NMDA. 
Contudo, não foram ainda identificadas as alterações no controlo do 
tráfego dos receptores GABAA durante a isquémia cerebral. Neste estudo, 
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combinámos abordagens bioquímicas e de imagiologia celular para 
investigar os mecanismos que regulam a internalização dos GABAAR após 
um estímulo de OGD transitório. Verificámos que a OGD diminui a 
interação GABAAR/Gefirina e induz a internalização dos GABAAR pela via 
endocítica dependente de clatrina. A redução da interação 
GABAAR/Gefirina e o aumento da internalização dos GABAAR é regulada 
por fosforilação, como demonstrámos pelos ensaios de co-
imunoprecipitação de proteínas com os receptores de superfície e pelo 
ensaio de “antibody-feeding”, respectivamente. Seguidamente, mostrámos 
que a OGD induz a desfosforilação e a internalização das subunidades β3 
dos receptores GABAA, expressos em grande quantidade no hipocampo e 
no córtex cerebral, duas regiões particularmente vulneráveis à 
excitotoxicidade. Os dados obtidos usando fosfo-mutantes da subunidade 
β3 dos GABAAR permitiram-nos concluir que a desfosforilação do 
receptor causada pela OGD e a sua consequente internalização 
contribuem para a morte neuronal. 
Após a internalização, os GABAAR são rapidamente reciclados e voltam 
para a membrana plasmática ou são encaminhados para os lisossomas a 
fim de serem degradados. O rumo que os GABAAR endocitados tomam 
depende da interacção das subunidades β1-3 com a proteína associada à 
huntingtina 1 (HAP1). Verificámos que a OGD reduz também a 
reciclagem dos GABAAR de volta para a membrana plasmática e diminui 
a sua interacção com a proteína HAP1. 
Em resumo, neste trabalho propomos um novo modelo no qual a 
dissociação do complexo GABAAR/Gefirina e a desfosforilação do receptor 
são passos fulcrais na diminuição da actividade GABAérgica durante a 
isquémia cerebral, com consequente morte neuronal. 
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SUMMARY 
 
Cerebral ischemia is a pathological condition caused by insufficient blood 
supply to the brain, which causes an imbalance between 
excitatory/inhibitory neurotransmission and excitotoxic neuronal death. 
The activity of neuronal networks in the CNS is mainly determined by the 
balance between glutamatergic and GABAergic neurotransmission, which 
is up- and down-regulated, respectively, during ischemic insults. In 
contrast with the role of glutamate in ischemic damage, which is largely 
documented, the alterations in inhibitory neurotransmission remain 
poorly understood. 
In vivo and in vitro studies have shown a downreregulation of GABAergic 
neurotransmission in the ischemic brain, both at the pre- and post-
synaptic levels. Exposure of hippocampal slices to oxygen and glucose-
deprivation induces an early release of GABA by exocytosis, followed by a 
delayed phase of neurotransmitter release mediated by reversal of the 
plasma membrane transporter. The downregulation of vesicular GABA 
transporters and the loss of ATP is likely to cause a delayed inhibition of 
exocytotic release of GABA. GABAA receptors (GABAAR) are the major 
players in fast synaptic inhibition in the CNS, and a downregulation of 
the surface expression of GABAARs has been shown in in vivo and in vitro 
models of ischemia. Furthermore, it was recently shown that stabilization 
of GABAAR surface expression correlates with neuroprotection in 
hippocampal and cerebrocortical neurons subjected to Oxygen Glucose 
Deprivation (OGD), and blockade of AP2/clathrin dependent 
internalization of GABAAR also reduces OGD induced cell death. 
Together, these evidence indicates that the number of GABAAR at the cell 
surface and receptor internalization play a key modulatory role in the 
induction of ischemic cell death, but the molecular mechanisms involved 
in receptor internalization have not been elucidated. 
In the present work we investigated the molecular mechanisms 
underlying GABAAR downregulation in cultured hippocampal neurons 
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subjected to OGD, an in vitro model of ischemia. Transient exposure of 
hippocampal neurons to OGD downregulated the total protein levels of 
GABAAR subunits characteristic of synaptic receptors (α1, α2, β3, γ2), 
but was without effect on the δ subunit that is typically found in 
extrasynaptic recepors. Similar results were observed in the infarct core 
of mice subjected to middle cerebral artery occlusion (MCAO). The 
downregulation of GABAAR subunits in cultured hippocampal neurons 
subjected to OGD was mediated by calpains. Quantitative PCR 
experiment showed a decrease in the expression levels of α1, α2, β2, β3 
and γ2 GABAAR subunits that was mediated by activation of glutamate 
receptor, but inhibition of transcription activity did not account for the 
downregulation of GABAAR subunit protein levels. 
The majority of GABAAR in the brain are assembled from at least 2 α-, 2 
β-, and 1 γ2-subunits. GABAAR present also a dynamic mobility between 
synaptic and extrasynaptic localization, being the accumulation of the 
receptor at the inhibitory synapses regulated by its scaffold protein 
gephyrin. Furthermore, the neuronal surface GABAAR are in a continue 
cycle between the plasma membrane and intracellular compartments, 
and the regulation of the total receptor surface expression plays a key 
role in the control of the postsynaptic pool size and the strength of 
synaptic inhibition. The GABAAR internalization rate is negatively 
regulated by phosphorylation of β3 or γ2 GABAAR subunits on their 
intracellular loop. Thus, NMDAR signaling is known to control the 
stability of synaptic GABAAR via calcineurin and GABAAR 
dephosphorylation. However, so far the alterations in the regulation of 
GABAAR trafficking that occur during pathological conditions, such as 
brain ischemia, remain completely unexplored. In this work we combined 
biochemical approaches and cell imaging to investigate the mechanisms 
regulating the internalization of GABAAR following transient OGD. We 
found that OGD decreases GABAAR/Gephyrin interaction and induces 
the internalization of GABAAR via clathrin dependent endocytosis. Both 
reduction of GABAAR/Gephyrin interaction and the increase in GABAAR 
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internalization were found to be regulated by phosphorylation as 
assessed by surface co-immunoprecipitation assay and antibody-feeding, 
respectively. Moreover, we demonstrated that OGD-induced 
dephosphorylation and internalization of β3 GABAAR subunits, which are 
present in a large proportion of receptor subtypes in the hippocampus 
and cortex, regions that are particularly vulnerable to excitotoxicity. 
Furthermore, our data showed that the OGD-induced receptor 
dephosphorylation and consequent internalization contributes to 
neuronal cell death, as demonstrated using a phospho-mutant of the β3 
GABAAR subunit.  
Following internalization, GABAARs are rapidly recycled back to the 
neuronal plasma membrane or targeted for lysosomal degradation. The 
decision regarding the sorting of endocytosed GABAARs depends on the 
interaction of GABAAR β1-3 subunits with huntingtin-associated protein 
1 (HAP1). We found that OGD also reduced the recycling of GABAAR back 
to the plasma membrane and decrease their interaction with the HAP1 
protein. Overall, we propose a new model in which GABAAR/Gephyrin 
dissociation and receptor dephosphorylation are key steps for GABAergic 
down modulation during cerebral ischemia and consequent neuronal cell 
death. 
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1.1.  CEREBRAL ISCHEMIA 
Stroke is the second most common cause of death worldwide and a 
leading global cause of disability (Lopez et al., 2006). From the clinical 
point of view the stroke may be classified as ischemic, intracerebral 
hemorrhagic and sub-arachnoid hemorrhagic (Warlow et al., 2003). 
Cerebral ischemia is the pathological condition in which the brain is 
subjected to hypoxia, normally resulting from an arterial obstruction that 
reduces the blood supply to the affected area. Brain ischemia is usually 
classified into two main groups, global and focal ischemia. During global 
ischemia the blood flow is transiently blocked to the entire brain, 
resulting in delayed and selective neuronal death. Focal ischemia is a 
consequence of a temporary or permanent obstruction of local blood 
supply injuring a specific area of the brain. 
In humans global ischemia occurs mostly as a consequence of cardiac 
arrest, open-heart surgery, profuse bleeding, or carbon monoxide 
poisoning. Only selected neuronal populations degenerate and die during 
a brief transient global ischemic insult, both in humans (Brillman, 1993; 
Petito et al., 1987; Roach et al., 1996; Swain et al., 1993) and in animal 
models (Schmidt-Kastner and Freund, 1991). The most vulnerable cells 
are pyramidal neurons in the cornu ammonis 1 (CA1) region of the 
hippocampus, hilar neurons of the dentate gyrus (DG), medium aspiny 
neurons of the striatum, pyramidal neurons in neocortical layers II, V, 
and VI, and Purkinje neurons of the cerebellum (Crain et al., 1988; 
Kirino, 1982). The molecular mechanisms underlying the cell-specific 
pattern of global ischemia–induced neuronal death are not well 
understood. 
Focal ischemia in humans occurs mainly as a consequence of stroke, 
cerebral hemorrhage, or traumatic brain injury. Stroke is mainly caused 
by a clot that occludes a cerebral artery, while in the other cases the 
ischemic injury is caused by a bursting of a weakened blood vessel in the 
brain and bleeding into the surrounding tissue (in cerebral hemorrhage 
or traumatic brain injury). 
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Tissues in risk of damage due to the cerebral artery occlusion are the 
core and penumbra. The core corresponds to the center of the stroke and 
receives essentially no blood supply; this area contains cells that are 
dependent on the affected blood vessel to obtain oxygen and nutrients 
required for their metabolism. The penumbra is the region surrounding 
the core and contains cells that receive a supply of oxygen and nutrients 
from nearby blood vessels, although it is not sufficient to keep the normal 
metabolic activity. The duration of the ischemic episode determines the 
extent or grade of damage (Memezawa et al., 1992). Although the infarct 
starts in the core, at its maximum it encompasses both core and 
penumbra, generally after 6 to 24 hours of permanent ischemia (Garcia 
et al., 1993).  
To improve the understanding of the etiology, prevention and treatment 
strategies for the different subtypes of stroke, it is very important to 
choose the most appropriate animal model according to the question to 
be addressed. Different animal models that have been developed to study 
specific aspects of this pathological condition are described in the next 
section. 
 
1.1.1. Animal models of brain ischemia 
Various models of stroke have been developed in the past decade, 
(Ginsberg and Busto, 1989; James et al., 2008), most of them performed 
in rodents (Bailey et al., 2009). These include models of global and focal 
ischemia, and in vitro and in vivo models are available. 
1.1.1.1. In vivo models 
1.1.1.2. Global ischemia models 
Global ischemia models mimic the cerebral damage that occurs after 
cardiac arrest. To study acute global ischemic damage in rodents, the 
four-vessel occlusion model (Pulsinelli and Brierley, 1979; Xu and 
Pulsinelli, 1994) and the two-vessel occlusion model (Smith et al., 1984; 
Wellons et al., 2000) are commonly used. Both methods cause extensive 
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bilateral forebrain injury. The first model consists in a permanent 
occlusion of both vertebral arteries and temporary ligation of the two 
common carotid arteries, while the second is obtained by temporary 
occlusion of the common carotid arteries combined with induced 
systemic hypotension. Chronic global hypoperfusion models in rodents 
include ligation of both common carotid arteries (Wakita et al., 1998) and 
bilateral common carotid artery stenosis using external microcoils 
(Wakita et al., 1998). Both models have been shown to produce mainly 
white matter lesions. 
1.1.1.3. Focal ischemia models 
Animal models of focal ischemia mimic the pathologic condition of stroke 
or cerebral infarction in humans (DeGirolami et al., 1984; Longa et al., 
1989; Nagasawa and Kogure, 1989). Since ischemic stroke in humans 
occurs mainly in the vascular territory of the middle cerebral artery 
(MCA) (del Zoppo et al., 1992), the models of MCA occlusion (MCAO) were 
developed to study the consequences of this clinical condition. In rodents 
MCAO induces long term sensorimotor deficits, cognitive deficits and 
impairment of postural and sensory reflexes (Bouet et al., 2007; Freret et 
al., 2009; Gerlai et al., 2000). Permanent or transient vessel occlusion is 
performed using endovascular or surgical approaches (Kuge et al., 1995; 
Robinson et al., 1975; Tamura et al., 1981; Tureyen et al., 2005), and 
may be either proximal or distal. In proximal occlusion, the MCA is 
occluded close to its branching from the internal carotid, before the 
origin of the lenticulostriate arteries (Ginsberg and Busto, 1989; 
McAuley, 1995). After MCAO, blood flow is reduced to less than 15% in 
the center of the stroke, or core. The region in which blood flow is 
reduced to less than 40% is defined as penumbra. In the case of distal 
MCAO, blood flow to the basal ganglia is not interrupted; consequently 
the damage is restricted to the neocortex. This type of occlusion can be 
induced surgically by means of a clip (Buchan et al., 1992) or by 
inducing thrombotic clots (Kilic et al., 1998; Markgraf et al., 1993), in 
combination with transient unilateral occlusion of the common carotid 
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arteries (Brint et al., 1988; Chen et al., 1986; Lipton, 1999). The 
reduction of blood flow achieved in the core and penumbra with distal 
MCAO is similar to that achieved in the proximal model. 
 
1.1.1.4. Oxygen and glucose deprivation (OGD) - In Vitro model 
Oxygen and glucose deprivation (OGD) is considered an in vitro model of 
global ischemia (Dawson et al., 1996; Goldberg and Choi, 1993; Martin et 
al., 1994). OGD is commonly performed in primary cultures of neurons 
or glia from different brain regions, such as the neocortex, hippocampus, 
cerebellum and hypothalamus of embryonic or early postnatal rats or 
mice. The effect of OGD on organotypic hippocampal slice cultures from 
perinatal rats, which keep the cellular organization of the hippocampus, 
has also been tested (Newell et al., 1995; Rimvall et al., 1987; Strasser 
and Fischer, 1995a; Strasser and Fischer, 1995b). Cultures of 
dissociated neurons and organotypic hippocampal slice cultures are 
usually incubated in a deoxygenated and glucose-free medium (OGD) to 
mimic the interruption of the oxygen and nutrient supply to the brain. 
Following the induction of in vitro ischemia, the cultures are often 
incubated in fresh or conditioned culture medium, in an oxygen-
containing atmosphere environment, to simulate the in vivo blood flow 
reperfusion period. The absence of blood vessels and blood flow makes 
OGD a simple model system to analyze but at the same time a less 
complete model. In the last years this model has been increasingly used 
to better understand the molecular injury pathways of brain ischemia. 
No animal model reproduces exactly the complexity of ischemic stroke. 
Therefore, the right model to choose depends on the research question 
being addressed. This is very important in order to prevent ambiguous 
interpretation of the results. 
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1.1.2. Ischemia-induced neuronal cell death 
Brain ischemia mediates neuronal death through a series of events that 
involve multiple interdependent molecular pathways. These pathways are 
thought to be activated following the extracellular accumulation of 
excitatory amino acids, especially glutamate (Faden et al., 1989). Global 
and focal ischemia induce neuronal death with hallmarks of both 
necrosis and apoptosis (Choi, 1996; Ginsberg and Busto, 1989). From a 
morphological point of view, necrotic cell death is generally characterized 
by early mitochondrial swelling and loss of integrity of the plasma 
membrane, with preservation of the nuclear membrane. In necrotic cell 
death two main states can be distinguished, edematous death and 
ischemic death. The former state is characterized by cytoplasm swelling, 
absence of plasma membrane blebbing and absence of microtubules. 
Furthermore, the endoplasmic reticulum, Golgi apparatus and polysomes 
appear as incomplete structures, and although the nucleus appears 
almost normal there is irregular chromatin condensation (Kalimo et al., 
1977; Kalimo et al., 1982). CA1 neurons undergoing delayed death in the 
rat and gerbil models of global ischemia show the characteristics of 
edematous death (Kirino and Sano, 1984; Petito and Pulsinelli, 1984). 
These edematous changes are typically observed upon global ischemia in 
the end stages of degeneration. The ischemic death is characterized by 
darkening and shrinkage of the nucleus and cytoplasm (Brown, 1977; 
Brown and Brierley, 1972; Inamura et al., 1987); the nuclear and plasma 
membranes become highly irregular, and therefore the cell shape 
changes.  
Unlike necrotic cells, apoptotic neurons in the ischemic brain exhibit 
characteristic morphologic features such as cytoplasmic shrinkage, 
chromatin condensation, dynamic membrane blebbing and apoptotic 
bodies. Moreover, in vitro experiments apoptotic cells do not exhibit 
membrane damage until the last stages of death, when the membranes 
become permeable to normally retained solutes (Martin et al., 1995; 
Matylevitch et al., 1998). A number of specific apoptotic death cascades 
involving different signaling molecules have now been identified. 
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Molecular hallmarks of apoptosis include phosphatidylserine exposure 
(translocation from the inner leaflet to the outer surface of the plasma 
membrane), activation of the cell surface receptors such as Fas/CD95, a 
member of the tumor necrosis factor (TNF) family of death receptors 
(Martin-Villalba et al., 1999), mitochondrial release of cytochrome c 
(Fujimura et al., 1998), activation of the caspases, notably caspase-3, 
(Namura et al., 1998) and DNA fragmentation (Benveniste et al., 1984; 
Cardell et al., 1989; Tominaga et al., 1993). The classical positive 
definition of necrotic cell death is based on morphological criteria, 
including early plasma membrane rupture and dilatation of cytoplasmic 
organelles, in particular mitochondria (Edinger and Thompson, 2004; 
Kroemer et al., 2005). However, this mode of cell death is also 
characterized by molecular signaling, including generation of ROS, ATP 
depletion (Tiwari et al., 2002) and changes in the actin cytoskeleton 
(Thomas et al., 2006b). 
 
1.1.2.1. Excitotoxic neuronal death 
Neuronal death in brain ischemia has been shown to involve multiple 
molecular pathways, largely triggered by the increase in extracellular 
glutamate (Faden et al., 1989). The massive release of synaptic glutamate 
following anoxia, during the ischemic episode (Choi, 1988), the release of 
the neurotransmitter by reversal of the plasma membrane transporters, 
and the inhibition of the glutamate reuptake mechanisms (Danbolt, 
1994; Kanner and Schuldiner, 1987; Nicholls and Attwell, 1990), 
contribute to the increase in the extracellular glutamate concentration, 
with consequent overactivation of the ionotropic glutamate receptors (N-
methyl-D-aspartate [NMDA] receptors [NMDAR], AMPA [α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid] receptors [AMPAR] and 
kainate receptors). Among the mechanisms involved in glutamate-
mediated excitotoxicity there are alterations in the intracellular ion 
concentration, especially Ca2+ and Na+, induced by excessive activation of 
glutamate receptors. The signaling by NMDAR and their intracellular 
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binding partners, in addition to the glutamate-mediated generation of 
free-radicals, play a key role in the activation of the cell death machinery.  
 
 
 
Figure 1.1. Activators and effectors of extrasynaptic NMDAR activity in brain 
ischemia.  
Brain ischaemia results in activation of extrasynaptic NMDAR through the reversal of 
the glutamate uptake system from astrocytes (a). Extrasynaptic NMDA receptor currents 
are also preferentially enhanced by ischaemia-induced activation of death-associated 
protein kinase (DAPK) (b). Increased extrasynaptic (but not synaptic) NMDAR activity in 
turn preferentially activates a number of pro-death pathways. Mitochondrial membrane 
potential (Ψm) is disrupted by extrasynaptic NMDAR activity. CREB, cyclic-AMP 
response element binding protein ; ERK, extracellular signal-regulated kinase; FOXO, 
forkhead box protein O; Jacob, juxtasynaptic attractor of caldendrin on dendritic 
boutons protein, STEP, striatal enriched tyrosine phosphatase. From (Hardingham and 
Bading, 2010) 
 
NMDARs and GluA2-lacking AMPAR allow the influx of Ca2+ and Na+ into 
postsynaptic cells (Gorter et al., 1997; Tsubokawa et al., 1994; 
Tsubokawa et al., 1996), while activation of AMPA receptors containing 
GluA2 subunits, as well as kainate receptors, further contributes to the 
increase in Na+ permeability, thereby depolarizing the postsynaptic 
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membrane. The massive rise in cytosolic Ca2+ levels is also due to 
activation of metabotropic glutamate receptors (mGluR), mGluR1 and 
mGluR5, that trigger the release of Ca2+ from inositol 1,4,5-triphosphate 
(InsP3)-sensitive intracellular stores via stimulation of phospholipase C 
(Oguro et al., 1995). Moreover, the excessive rise in extracellular 
glutamate concentration allows the activation of extrasynaptic NMDA 
receptors, with a consequent influx of toxic amounts of Ca2+ that promote 
the shutoff of the CREB-initiated program of gene expression which 
promotes cell survival. This response induced by extrasynaptic NMDAR 
contrasts with the role of synaptic NMDAR which are coupled to the 
activation of CREB, thereby promoting cell survival (Hardingham and 
Bading, 2003; Lonze and Ginty, 2002). This evidence indicates that the 
site of NMDAR mediated Ca2+ entry into cells critically influences the fate 
of neurons (Hardingham and Bading, 2010; Hardingham et al., 2002). 
Interestingly, contemporaneous activation of synaptic and extrasynaptic 
NMDARs also shuts off CREB (Hardingham et al., 2002).  
The excessive release and spillover of glutamate in brain ischemia allows 
the stimulation of both populations of NMDAR, ultimately leading to cell 
death. It has been proposed that the breakdown of regular synaptic 
transmission and the overactivation of extrasynaptic GluN2B-containing 
NMDAR are responsible for neuronal death in brain ischemia (Benveniste 
et al., 1984; Rossi et al., 2000) (Fig. 1.2). However, at this point the 
relative role of synaptic and extrasynaptic NMDAR activation in 
excitotoxicity is still controversial (Sattler et al., 2000). The observations 
supporting a preferential neuroprotective role of synaptic GluN2A-
containing NMDAR (Hardingham et al., 2002; Leveille et al., 2008) 
contrast with those pointing to a role in excitotoxicity (Papouin et al., 
2012). Evidence suggested that the subunit composition of NMDAR plays 
a more important role in determining the downstream pathways activated 
than the cellular localization of the receptors (Liu et al., 2007). For 
example, during the early period of development only GluN2B-containing 
receptors are expressed and, therefore, at this stage the cells are more 
vulnerable to excitotoxic events. During development, with the 
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appearance of GluN2A-containing receptors, the cells become more 
resistant to these harmful factors (Thomas et al., 2006a; Zhou and 
Baudry, 2006). 
The role of AMPAR in excitotoxic cell death has been related to the 
expression of GluA2 subunits. The relative expression of GluA2 in 
neurons is dynamic, being regulated in a cell-specific manner during 
development and remodeled by activity and in pathological conditions 
(Friedman et al., 1994; Prince et al., 1995), such as ischemia (Tanaka et 
al., 2000). This subunit governs the biophysical properties of AMPAR, 
including their Ca2+ permeability (Hollmann et al., 1991; Verdoorn et al., 
1991). GluA2-lacking AMPAR are an important route of Ca2+ and Zn2+ 
entry into insulted neurons (Weiss and Sensi, 2000). In the adult brain, 
hippocampal neurons express high levels of GluA2 and exhibit relatively 
low Ca2+ influx via AMPAR. However, injurious stimuli, such as ischemia, 
induce the suppression of GluA2 mRNA, with a consequent 
downregulation in the expression of the protein in vulnerable CA1 
neurons. This effect is subunit-specific and is observed in a cell-specific 
manner before the onset of cell death (Garthwaite and Garthwaite, 1989; 
Paschen et al., 1996; Pellegrini-Giampietro et al., 1997; Takuma et al., 
1999).  
The strength of the ischemic insult influences the cytosolic Ca2+ 
concentration and determines the mode of cell death. In fact, stronger 
insults induce a massive increase in cytosolic Ca2+ that results in 
necrotic cell death (Choi, 1995), while less severe insults cause a smaller 
elevations in Ca2+ and may trigger apoptosis (Bonfoco et al., 1995; Yu et 
al., 2001). 
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FIGURE 1.2. Opposing effects of synaptic and extrasynaptic NMDAR signalling on 
gene expression.  
(A) Phosphorylated CREB at serine 133 recruits its co-activator CREB binding protein 
(CBP). This phosphorylation is mediated by the fast-acting nuclear Ca2+/calmodulin-
dependent protein (CaM) kinase pathway (Aa) and by the slower acting (but longer 
lasting) Ras–extracellular signal-regulated kinase 1/2 (ERK1/2) pathway (Ab), both of 
which promoted by activation of synaptic NMDAR. CBP is subject to Ca2+-mediated 
transactivation by nuclear Ca2+ dependent CaM kinase IV which phosphorylates CBP 
(Ac). Synaptic NMDAR-induced Ca2+ signals promote TORC import into the nucleus 
through calcineurin-dependent dephosphorylation (Ad). TORC acts by assisting in the 
recruitment of CBP to CREB. In contrast, extrasynaptic NMDAR suppress CREB activity 
through inactivation of the Ras–ERK1/2 pathway 41 (Ae) and by inducing the nuclear 
translocation of juxtasynaptic attractor of caldendrin on dendritic boutons protein 
(Jacob), which promotes CREB dephosphorylation (Af). (B) Opposing effects of synaptic 
and extrasynaptic NMDAR signalling on forkhead box protein O (FOXO)-dependent gene 
expression. Synaptic NMDAR activity suppresses FOXO activity by promoting the Akt-
mediated phosphorylation and nuclear export of FOXOs (Ba), of which FOXO1 and 
FOXO3 are the predominant neuronal subtypes. FOXO1 is also regulated 
transcriptionally by FOXOs and thus signals that cause FOXO export also result in the 
suppression of FOXO1 transcription. In contrast, bath activation of NMDAR, which also 
triggers extrasynaptic NMDAR activity, stimulates FOXO nuclear import (Bb), an event 
that contributes to excitotoxic cell death by promoting the transcription of pro-death 
genes. Synaptic NMDAR activity can exert a long-lasting block on this import signal 
(Bc), but the mechanism involved remains unclear. Bim, Bcl2-interacting mediator of 
cell death; Fasl, Fas ligand; FBS, FOXO binding site; Pi, inorganic phosphate; PI3K, 
phosphoinositide 3 kinase; Txnip, thioredoxin-interacting protein. From (Hardingham 
and Bading, 2010) 
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1.1.2.2.  Intracellular mediators of excitotoxic cell death 
Under physiological condition the calcium ions are intracellular 
messengers involved in the regulation of important functions, including 
synaptic activity, membrane excitability, exocytosis and enzyme 
activation (Lee et al., 2005; Yadavalli et al., 2004). A dysregulation of the 
[Ca2+]i homeostases, with a dramatic increase in the cytoplasmatic 
calcium levels, is one of the first indicators of neuronal cell death (Banay-
Schwartz et al., 1994; Bouet et al., 2007; Nixon, 2003; Polster et al., 
2005). The [Ca2+]i overload under excitotoxic conditions contributes to 
neuronal injury through activation of different classes of enzymes, 
including calpains (Araujo et al., 2004; Bano et al., 2005; Lee et al., 
2005; Lob et al., 1975). Calpain activation was initially implicated in the 
necrotic process, but it is now accepted that these cysteine proteases 
play a prominent role in the apoptotic process (Liou et al., 2005). 
The excessive activation of calpains contributes to neuronal death by 
cleaving proteins with different functions. Calpain overactivation leads to 
cytoskeletal protein breakdown, with a consequent loss of structural 
integrity and disturbance of axonal transport, and finally inducing 
neuronal death (Yamashima, 2004). The disruption of the cytoskeleton is 
mediated by the cleavage of several essential cytoskeletal proteins of the 
axons (Kieran and Greensmith, 2004), including tau, microtubule-
associated protein 2 (MAP2), neurofilaments, and spectrin (Goll et al., 
2003; Liu et al., 2008). For example, calpains were shown to be involved 
in the proteolysis of tau during retinal cell death (Benuck et al., 1996). In 
cerebellar granule neurons, excitotoxic stimulation with glutamate also 
induces the cleavage of myosin Va by calpains, while calpain inhibitors 
improved neuronal viability by preventing myosin Va proteolysis (Alavez 
et al., 2004). The excessive activation of calpains under excitotoxic 
conditions also leads to the abnormal cleavage of mitochondrial proteins. 
The cleavage of apoptosis inducing factor (AIF), a protein associated with 
the inner mitochondrial membrane, releases this protein to the cytosol 
(Pike et al., 2001). AIF is then translocated to the nucleus, activating 
caspase-independent apoptosis (Daugas et al., 2000; Polster et al., 2005). 
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Calpains are also implicated in the degradation of apoptotic proteins 
such as Bid (Li et al., 1998; O'Donovan et al., 2001). In addition to the 
direct effects of Ca2+, it was suggested that calpains may be activated by 
DNA damage (Sedarous et al., 2003). In particular, calpains regulate the 
activation of p53 (Saulle et al., 2004) and calpain inhibitors were shown 
to reduce the  p53 activity induced by DNA damage, most likely by 
preventing the release of cytochrome c and the activation of caspases 
(Sedarous et al., 2003). These data suggest that calpains are modulators 
of apoptosis stemming from DNA damage upstream of p53.  
Calpains may also target plasma membrane receptors and ion 
transporters, thereby affecting neuronal death under excitotoxic 
conditions. Thus, calpains were shown to cleave NMDA receptors in 
hippocampal neurons exposed to toxic concentrations of glutamate 
(Adamec et al., 1998). Overactivation of NMDA also induces the cleavage 
of mGluR1a through a calpain-dependent mechanism, thereby altering 
the mGluR1a signaling and contributing to excitotoxic neuronal damage 
(Xu et al., 2007). It was also shown that calpains cleave the plasma 
membrane Na+/Ca2+ exchanger during brain ischemia in neurons 
undergoing excitotoxicity (Bano et al., 2005). The proteolytic inactivation 
Na+/Ca2+ exchanger is responsible for the delayed excitotoxic 
upregulation of Ca2+ and the consequent neuronal death. In this model, 
the overexpression of calpastatin (an endogenous calpain inhibitor) 
protects neurons from excitotoxic death by decreasing secondary Ca2+ 
overload (Bano et al., 2005). 
NO is also considered an important downstream mediator of NMDA-
induced excitotoxicity. The high cytosolic Ca2+ concentration resulting 
from the excessive activation of NMDAR stimulates the neuronal isoform 
of nitric oxide synthase (nNOS), which binds Ca2+-calmodulin complexes 
and forms NO and citrulline from arginine (Bredt et al., 1992; 
Garthwaite, 1991; Kumura et al., 1996). Several studies implicate the 
free radical form of NO and the superoxide anion (O2-) in the oxidative 
damage of cellular DNA, lipid peroxidation, and excitotoxic cell death 
(Choi, 1990; Choi, 1995; Liu et al., 2001; Tsubokawa et al., 1992). In this 
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pathway NO reacts with the superoxide anion to form peroxynitrite, a 
cytotoxic oxidant that induces DNA damage, thereby triggering apoptotic 
cell death (Choi, 1995; Takei and Endo, 1994). 
NMDAR-mediated influx of Ca2+ also activates phospholipase A2 which 
releases arachidonic acid, an unsaturated fatty acid, and promotes the 
production of free radicals via activation of the lipoxygenase and 
cyclooxygenase pathways (Aronowski et al., 1996). Cyclooxygenase 
catalyzes the addition of two molecules of O2 to arachidonic acid to 
produce prostaglandin PGG2, which is rapidly peroxidized to PGH2 with 
concomitant release of superoxide anion (Aguilar et al., 1996). The 
metabolism of free arachidonic acid is thought to be a major source of 
superoxide anion. Free radicals damage proteins by oxidation of side 
chains and modification of disulfide bonds. Moreover, they inactivate and 
damage nucleic acids. The oxidative damage caused by free radicals 
results from single- and double-stranded breaks in DNA, chemical 
modification of nucleic acid bases, breaking the glycosylic bond between 
ribose and individual bases, and by crosslinking proteins to DNA strands 
(Liu et al., 2001). 
Overall Ca2+ and Zn2+ are critical players in ischemic cell death (Choi and 
Koh, 1998). In addition to the mechanisms mentioned above, high 
cytosolic Ca2+ contributes to neuronal death by depleting the energy 
stores of the cell due to activation of Ca2+-ATPases and uncoupling of 
mitochondrial oxidative phosphorylation, leading to acute swelling of 
dendrites and cell bodies. Moreover, high [Ca2+]i levels activate Ca2+-
sensitive transcription factors, phospholipases, endonucleases, and 
proteases (Choi and Koh, 1998). The dysregulation of the proteolytic 
activity not only affects intracellular proteins, including cytoskeletal 
proteins such as actin and spectrin (Furukawa et al., 1997) (see above), 
but also downregulate extracellular proteins (e.g. extracellular matrix 
proteins like laminin) (Chen and Strickland, 1997). Similar to the role of 
Ca2+, the neurotoxic effects of Zn2+ in brain ischemia have been 
attributed to disruption of mitochondrial function (impairment of 
glycolysis and energy production, and inhibition of respiration) and 
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potentiation of AMPAR-mediated currents (Weiss and Sensi, 2000). 
Furthermore, Zn2+ influx via GluA2-lacking AMPAR also induces the 
production of free radicals, such as mitochondrial superoxide, in injured 
neurons (Bonfoco et al., 1995; Sensi et al., 1999). 
The metabolic stress caused by energy depletion also contributes to 
neuronal cell death in cerebral ischemia. Neurons have a relatively high 
consumption of oxygen and glucose, and depend almost exclusively on 
oxidative phosphorylation for energy production. During the ischemic 
episode, impairment of cerebral blood flow restricts the delivery of 
substrates, particularly oxygen and glucose, and impairs the energetics 
required to maintain ionic gradients (Martin et al., 1994). The rapid 
decrease in ATP levels induces neuronal depolarization, promoting cell 
death by necrosis in the core region. Energetic impairment also reverses 
the operation of glutamate transporters in astrocytes and neurons, 
leading to an extracellular accumulation of the neurotransmitter. The 
resulting overactivation of ionotropic glutamate receptors contributes to 
cells swelling (edema) and consequent rupture of the plasma membrane 
(Meldrum and Garthwaite, 1990). Apoptotic and necrotic stimuli also 
compromise mitochondria integrity by the disruption of the 
mitochondrial membrane. The apoptotic cascade can be initiated by the 
release of cytochrome c into the cytoplasm, allowing the formation of the 
apoptosome, the signaling complex required for activation of caspase-9 
(Broughton et al., 2009). The precise mechanisms by which the integrity 
of mitochondrial membrane breaks down are unknown, but Bcl-2 family 
members are known to play a critical role (Hengartner, 2000; Kroemer 
and Reed, 2000). 
Other intracellular mechanisms triggered by ischemia are related with 
transcriptional pathways. The transcription factors that are thought to 
contribute to the changes in gene expression after global ischemia 
include CREB and nuclear factor kappa B (NF- kB), which control pro-
survival programs, and the forkhead family of transcription factors and 
REST/NRSF, which direct pro-death pathways in adult neurons. As 
previously described, although the influx of Ca2+ via synaptic NMDAR 
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induces the activation of CREB and promote neuronal survival, the 
massive glutamate release during cerebral ischemia induces the influx of 
Ca2+ via extrasynaptic NMDAR eliciting CREB shutoff (Hardingham and 
Bading, 2003; Lonze and Ginty, 2002; Riccio and Ginty, 2002). 
Under physiologic conditions the transcription factor NF-κB exists in the 
inactive form, composed by the transcription factor dimer bound to the 
IκB (inhibitor of NF-κB) protein, which maintains NF-κB inactive. Upon 
focal ischemia NF-κB is activated due to the phosphorylation and 
proteasomal degradation of IκB. Activated NF-κB translocates to the 
nucleus, where it binds to upstream regulatory elements in NF-κB-
responsive genes (Schneider et al., 1999). Upon activation, NF-κB plays 
an important role in regulating neuronal survival. Accordingly, targeted 
deletion of NF-κB significantly reduces ischemic damage, suggesting a 
cell death–promoting role of NF-κB in focal ischemia (Schneider et al., 
1999). 
Dysregulation of REST and its target genes is also implicated in global 
ischemia (Calderone et al., 2003), which triggers a pronounced 
upregulation of REST mRNA and protein in selectively vulnerable CA1 
neurons. 
Finally, inflammatory responses are also involved in the pathogenesis of 
ischemia-induced neuronal death (Dirnagl et al., 1999). Ischemia-hypoxia 
triggers the activation of transcription factors such as NF-κB, hypoxia-
inducible factor-1 (HIF-1), interferon regulatory factor-1 and signal 
transducers and activators of transcription (STATs). In particular STAT3 
induces the expression of a group of proinflammatory target genes, such 
as platelet-activating factor and the cytokines TNFα and IL-1β (Ishibashi 
et al., 2002). Cytokines play a mutifacted response in the immune 
response following stroke. For example IL-1 can inhibit, exacerbate, or 
induce neuronal cell damage and death, while TNF-α induces apoptosis 
in a variety of cells, and can stimulate a proadhesive and pro-
inflammatory state, in addition to the production of reactive oxygen 
species (ROS) in the endothelium, further exasperating the immune 
response (Tuttolomondo et al., 2008).  
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1.2. GABAA RECEPTOR-MEDIATED NEUROTRANSMISSION  
1.2.1. GABAAR structure and trafficking  
Inhibitory neurotransmission in the Central Nervous System (CNS) is 
largely mediated by γ-aminobutyric acid (GABA). GABA exerts its 
inhibitory control by acting on two classes of receptors with distinct 
electrophysiological and pharmacological properties. GABA type A 
receptors (GABAAR) are ionotropic fast-acting ligand-gated chloride 
channels (Sieghart, 2006), while GABA type B receptors (GABABR) belong 
to the metabotropic G protein-coupled receptor superfamily and produce 
slow and prolonged inhibitory responses (Bettler and Tiao, 2006). 
Under normal physiological conditions GABAAR respond to the binding of 
GABA by opening an integral chloride channel and allowing chloride to 
enter the neuron. The result is a membrane hyperpolarization and 
neuronal inhibition. Deficits in GABAAR function have been associated 
with both psychiatric diseases and neurological disorders (Benarroch, 
2007; D'Hulst and Kooy, 2007; Lewis and Gonzalez-Burgos, 2006; 
Rudolph and Mohler, 2004; Thompson-Vest et al., 2003). 
Many distinct but homologous GABAAR subunits (α 1–6, β1–3, γ1–3, δ, ε, 
θ, π and ρ1–3) have been cloned and sequenced from the mammalian 
CNS. These receptor subunits share a common ancestral structure that 
includes an extracellular N-terminal domain, four transmembrane 
domains (TM1-4) and an extended cytoplasmic loop region between TM3 
and TM4. The latter sequence is subject to posttranslational 
modifications and interacts with various regulatory, chaperone, and 
scaffolding proteins (Fig. 1.4). The various GABAAR subunits are 
preferentially assembled to form heteropentameric receptors. Despite the 
vast theoretically possible number of heteropentameric assemblies, only 
a limited number of receptor subtypes are expressed physiologically 
(Sieghart and Sperk, 2002). The majority of GABAAR subtypes in the 
brain are composed of α1β2γ2, followed by α2β3γ2 and α3β3γ2 (Chang et 
al., 1996; Knight et al., 2000; Massaria et al., 1976; Tretter et al., 1997). 
GABAAR with different subunit compositions have different physiological 
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and pharmacological properties, are differentially expressed throughout 
the brain and are targeted to different subcellular regions. Receptors 
composed of α1, α2 or α3 subunits together with β and γ subunits are 
benzodiazepine ‑ sensitive, and largely synaptically located, mediating 
most phasic inhibition in the brain (Rudolph and Mohler, 2004). Instead, 
GABAAR composed of α4 or α6 subunits, together with β and δ subunits, 
are predominantly extrasynaptic, mediate tonic inhibition and are 
insensitive to benzodiazepine modulation (Brunig et al., 2002). GABAAR 
are also present at presynaptic sites (Draguhn et al., 2008) (Fig. 1.3). 
 
FIGURE 1.3. GABAAR structure and 
neuronal localization.  
A) GABAAR are ligand-gated ion-
channels formed by oligomerization of 
5 subunits. GABAAR subunits consist 
of four hydrophobic transmembrane 
domains (TM1–4), with TM2 believed 
to line the pore of the channel. The 
large extracellular amino terminus is 
the site of GABA binding, and also 
contains binding sites for 
psychoactive drugs, such as 
benzodiazepines (BZ). Each receptor 
subunit also contains a large 
intracellular domain between TM3 
and TM4 that is the site for 
interaction with various proteins, as 
well as for various post-translational modifications that modulate receptor activity. B) 
Five subunits belonging to seven subunit subfamilies (α, β, γ, δ, ε, θ and π) assemble to 
form a heteropentameric Cl--permeable channel. Most GABAAR expressed in the brain 
consist of two α subunits, two β subunits and one γ subunit; the γ subunit can be 
replaced by δ, ε, θ or π subunits. Binding of the neurotransmitter GABA occurs at the 
interface between the α and β subunits and triggers the opening of the channel, 
allowing the rapid influx of Cl- into the cell. BZ binding occurs at the interface between 
the α (1, 2, 3 or 5) and γ subunits, and potentiates GABA-induced Cl- flux. C) GABAAR 
composed of α (1–3) subunits together with β and γ subunits are thought to be primarily 
synaptically localized, whereas α5βγ receptors are located largely at extrasynaptic sites. 
Both types of GABAAR are BZ sensitive. In contrast, receptors composed of α (4 or 6) βδ 
subunits are BZ insensitive and localized at extrasynaptic sites. From (Jacob et al., 
2008) 
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FIGURE 1.4. GABAAR subunit structure and intracellular loop sequences  
A) Schematic representation of GABAAR heteropentamers consisting of two α, two β, and 
a single γ2 subunit. B) Every subunit includes an extracellular N-terminal domain, four 
transmembrane domains (TM1-4) separated by an extended cytoplasmic loop region 
between TM3 and TM4, and a short extracellular C terminus. The cytoplasmic loop and 
the TM4 regions of the γ2 subunit are essential for postsynaptic clustering of GABAAR 
(see also Figure 1.3). C) Sequences of the cytoplasmic loop regions of representative 
subunits (γ2, β3, α2) with amino acid numbers referring to mature polypeptides from 
the mouse. Interaction sites for binding partners are marked by brackets beneath the 
sequence, along with amino acid numbers of known Ser/Thr and Tyr phosphorylation 
sites. Phosphorylation sites are shown in blue; Lys residues representing putative 
ubiquitination sites are in orange. From (Luscher et al., 2011) 
 
GABAAR are assembled from their component subunits in the 
endoplasmic reticulum (ER). The assembly process plays a critical role in 
determining the diversity of receptor subtypes expressed on the neuronal 
plasma membrane. Proteins only exit the ER if they have achieved their 
correctly folded conformation, and misfolded or unassembled proteins are 
retrotranslocated from ER for degradation in the proteasome, restricting 
the number of subunit combinations that can access the cell surface 
(Kittler et al., 2002) (Fig. 1.5). Following assembly in the endoplasmic 
reticulum, the receptors are trafficked to the cell surface where there is 
40 
dynamic regulation of their surface expression. Such regulation 
profoundly affects the efficacy of GABAergic transmission and the overall 
excitability of the central nervous system. The entry of GABAAR into the 
secretory pathway is regulated by interaction of α and β subunits with 
PLIC-1 (the protein that links integrin-associated protein with the 
cytoskeleton-1) (Bedford et al., 2001). PLIC-1 contains an ubiquitin-like 
(ubl) proteasome binding domain and ubiquitin-associated (uba) domain. 
The interaction with these two domains interferes with ubiquitin-
mediated proteolysis of diverse substrates (Kleijnen et al., 2003; Kleijnen 
et al., 2000; Walters et al., 2002; Wu et al., 1999). PLIC-1 promotes the 
surface expression of GABAAR in neurons (Bedford et al., 2001), 
presumably by inhibiting ubiquitination and proteasomal degradation of 
α and β subunits. 
Along the secretory pathway the newly synthesized and assembled 
receptors are palmitoylated by the Golgi apparatus-specific protein with 
the DHHC zinc finger domain (GODZ), and interact with the brefeldin‑A‑
inhibited GDP/GTP exchange factor 2 (BIG2) and with the microtubule-
associated protein GABAAR associated protein (GABARAP) to reach the 
cell surface by mechanisms that are not completely understood. More 
specifically, GODZ interacts with the GABAAR γ2 subunit recognizing a 
14-amino acid cysteine-rich domain conserved in the intracellular 
domain of γ1–3 subunits, NH2-terminal to the GABARAP binding site 
(Rathenberg et al., 2004). The γ2 subunit is palmitoylated at all four 
cysteines within the GODZ binding domain (Rathenberg et al., 2004). 
Mutation of these cysteine residues resulted in a loss of GABAAR clusters 
at the cell surface (Rathenberg et al., 2004). Therefore, GODZ controls 
GABAAR trafficking in the secretory pathway and the delivery of these 
receptors to the plasma membrane (Keller et al., 2004). 
BIG2 has an important role in the vesicular trafficking of GABAAR to the 
plasma membrane. This protein can bind to the intracellular domain of 
the β3 subunit, and has a high binding affinity for the intracellular loops 
of all β subunits (Charych et al., 2004). BIG2 is largely localized to the 
trans-Golgi network (Charych et al., 2004) and has a known role in 
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membrane budding and vesicular transport from the Golgi apparatus 
(Moss and Vaughan, 1995). These data suggest that the main function of 
BIG2 is in the intracellular trafficking of GABAAR to the plasma 
membrane.  
GABARAP is a 13.9 kDa microtubule-associated protein that interacts 
with the γ subunit cytoplasmic loop through its N-terminal domain 
(Wang et al., 1999; Wang and Olsen, 2000). The same protein also binds 
tubulin C-terminal region, suggesting that it may link the receptor to 
microtubule networks (Wang and Olsen, 2000). Several evidence indicate 
a role for GABARAP in the transport of GABAAR to the plasma 
membrane, but GABARAP is not essential for receptor surface expression 
since GABARAP knockout mice do not display alterations in either the 
total number of GABAAR or in their synaptic localization (O'Sullivan et 
al., 2005). In addition, GABARAP promotes clustering of receptors (Chen 
et al., 2000; Everitt et al., 2004) by a mechanism that requires 
polymerized microtubules and both the γ2 subunit and tubulin binding 
regions of GABARAP (Chen et al., 2000). 
 
FIGURE 1.5. GABAAR trafficking in the secretory pathway is regulated by multiple 
receptor-associated proteins.  
GABAAR are assembled within the ER and transported to the Golgi. Within the ER, 
unassembled receptor subunits are subjected to polyubiquitination that targets them 
for proteasomal degradation, a phenomenon that is dependent on the level of neuronal 
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activity. This process is negatively regulated by Plic-1, which binds directly to the 
receptor α- and β-subunits, prolonging their ER residence times. Within the Golgi, 
GABAAR receptors bind to complexes of GABARAP/NSF, facilitating their transport to 
the plasma membrane. BIG2 is also found within the Golgi and modulates receptor 
forward trafficking. GODZ is a Golgi resident palmitoyltransferase that regulates 
palmitoylation of γ subunits, a critical step in the delivery of GABAAR to the plasma 
membrane. Finally, PRIP proteins also play essential roles in the trafficking of GABAAR 
and in modulating their phosphorylation state. From (Vithlani et al., 2011) 
 
1.2.2. Regulation of GABAAR cell surface expression 
GABAAR can be delivered to the cell surface either as newly assembled 
channel complexes, via de novo secretory pathway, or reinserted 
following internalization. They can access inhibitory postsynaptic 
specializations or extrasynaptic sites, depending on their subunit 
composition. Once on the neuronal surface GABAAR are not static but 
are in a continue cycle between the plasma membrane and intracellular 
compartments. The regulation of receptor exo- and endocytosis plays a 
key role in the control of the postsynaptic pool size and the strength of 
synaptic inhibition. Furthermore, GABAAR were shown to be inserted into 
and removed from the plasma membrane exclusively at extrasynaptic 
sites (Bogdanov et al., 2006; Thomas et al., 2005). This aspect 
corroborates the importance of lateral diffusion for their postsynaptic 
specialization. 
The membrane localization of GABAAR is highly selective in terms of 
receptors subtypes and the subunit composition is determinant for the 
postsynaptic targeting and clustering of these receptors. Although the 
molecular mechanisms that control GABAAR accumulation at inhibitory 
synapses are not fully understood, a number of receptor-associated 
proteins and cytoskeletal elements present at GABAergic postsynaptic 
densities (PSD) are involved in this process. 
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1.2.2.1. Postsynaptic GABAA receptors 
The most important protein for the stabilization of GABAAR at synapses 
is gephyrin, considered the principal subsynaptic scaffold protein of both 
GABAergic and glycinergic synapses (Fritschy et al., 2008). Gephyrin, a 
93 KDa polypeptide (Pfeiffer et al., 1982), is a largely expressed multi-
functional protein, and also plays an essential in the postsynaptic 
clustering of glycine receptors (Feng et al., 1998; Kirsch et al., 1993; Prior 
et al., 1992; Sola et al., 2004). The role of gephyrin in the clustering of 
GABAA and glycine receptors results from its interaction both with 
microtubules (Kirsch et al., 1995) and with several regulators of 
microfilament dynamics, including profilin I and II (Mammoto et al., 
1998). The direct interaction between GABAAR and gephyrin was firstly 
observed for the α2 subunit (Saiepour et al., 2010). Additional studies 
allowed the identification of gephyrin interaction motifs in the 
homologous region of α1 and α3 (Mukherjee et al., 2011; Tretter et al., 
2011). Moreover recently a novel gephyrin-binding motif was identified in 
the GABAAR β2 and β3 large cytoplasmic loops (Kowalczyk et al., 2013). 
At postsynaptic sites gephyrin is known to oligomerize and forms clusters 
(Saiyed et al., 2007) through the N-terminal gephyrin domain (G-
gephyrin), that assumes a trimeric structure (Schwarz et al., 2001; Sola 
et al., 2001), and the C-terminal domain (E- gephyrin) that forms a dimer 
(Schwarz et al., 2001; Sola et al., 2001; Xiang et al., 2001). The linker 
region between the E and G domains is thought to interact with 
microtubules (Ramming et al., 2000).  
The gephyrin structure allows the organization of a microtubule and 
microfilament-associated hexagonal protein lattice that may facilitate the 
spatial distribution of receptors in the postsynaptic membrane. However, 
it is not yet clear how structural changes affect the postsynaptic scaffold 
organized by gephyrin and the relative role played by GABAAR versus 
gephyrin phosphorylation. Recent studies showed that the dynamics of 
gephyrin clustering is regulated by neuronal activity (van Versendaal et 
al., 2012; Vlachos et al., 2012). Considering that phosphorylation and 
intracellular Ca2+ rises make gephyrin susceptible to proteolysis by 
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calpain (Tyagarajan et al., 2011), it is reasonable to hypothesize that 
neuronal gephyrin dynamics may be phosphorylation-dependent. 
However, few data are available on the functional characterization of the 
diverse phosphorylation sites that have been identified on gephyrin 
(Kuhse et al., 2012; Specht et al., 2011; Tyagarajan and Fritschy, 2010; 
Tyagarajan et al., 2013b; Zita et al., 2007). Gephyrin phosphorylation 
status directly impacts on GABAergic synaptic function, presumably by 
allowing formation of synapses (Tyagarajan et al., 2011) and recruitment, 
or stabilization, of GABAAR to the postsynaptic density. Furthermore, 
recent work demonstrated that calpain activation is a general mechanism 
to confine gephyrin to the postsynaptic cluster, in a phosphorylation-
dependent manner (Tyagarajan et al., 2013b). Overall, multiple signaling 
cascades converge onto gephyrin to modify its scaffolding properties at 
the GABAergic postsynaptic density and to influence synaptic function in 
the CNS. 
 
1.2.2.2. Extrasynaptic GABAA receptors 
The clustering of GABAAR at the extrasynaptic site is mediated by 
radixin. This protein belongs to the family of ERM (ezrin, radixin, moesin) 
proteins, which are known to link transmembrane proteins to the actin 
cytoskeleton. Radixin is an α5 GABAAR subunit-interacting protein and is 
essential for extrasynaptic clustering of α5βγ2 receptors (Loebrich et al., 
2006). In fact, among different γ2-containing GABAAR only those 
composed by α5βγ2 subunits showed an extrasynaptic distribution. The 
extrasynaptic clustering of α5-containing receptors was abolished when 
neurons were transfected with a dominant-negative radixin, but no no 
effect was observed on α5-containing GABAAR surface expression under 
the same conditions (Loebrich et al., 2006), suggesting that the synaptic 
accumulation of GABAAR containing α5 subunits is prevented by a 
radixin-independent mechanisms. Nevertheless, the functional relevance 
of α5βγ2 receptor clustering at the extrasynaptic region is not known. 
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1.2.2.3. Lateral diffusion of GABAA receptors 
It is well established that synaptic strength is influenced by the number 
of postsynaptic receptors. In addition to the classical machinery of 
receptor endocytosis or membrane insertion/recycling, the lateral 
diffusion of receptors from and into the synaptic regions also plays an 
important role in the regulation of GABAAR density at the synapse (Fig. 
1.6) (Dahan et al., 2003; Groc et al., 2004; Tardin et al., 2003). Both 
single particle tracking (SPT) and electrophysiological studies have 
demonstrated that GABAAR are rapidly exchanged between synaptic and 
extrasynaptic domains by lateral diffusion (Bogdanov et al., 2006; Jacob 
et al., 2005; Thomas et al., 2005). SPT has shown a rapid exchange 
between the extrasynaptic and synaptic populations of GABAAR and this 
process was found to be modulated by the activity of protein phosphatase 
2B (PP2B). This calcium dependent mechanism activated via NMDA 
receptors leads to an increase in the lateral mobility of GABAAR and 
reduces the size of inhibitory synapses, a process that favors neuronal 
depolarization (Bannai et al., 2009).  
GABAAR clusters are stabilized by gephyrin in the postsynaptic areas. In 
fact, fluorescence recovery after photobleaching (FRAP) experiments 
showed significantly higher fluorescence recovery rates at extrasynaptic 
sites than at postsynaptic membrane domains, indicating a greater 
mobility of extrasynaptic GABAAR when compared with the postsynaptic 
population of receptors (Jacob et al., 2005). Gephyrin knock-down 
significantly increased FRAP recovery rates at the synapse, indicating 
that the GABAAR mobility at postsynaptic sites is controlled by direct or 
indirect interactions with the scaffold protein (Jacob et al., 2005). 
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FIGURE 1.6. Dynamic regulation of receptor lateral mobility at the GABAergic 
synapse. GABAAR are inserted into the plasma membrane at extrasynaptic sites from 
where they can then diffuse into synaptic sites. Lateral diffusion (indicated by the 
horizontal single-headed arrows) in the plasma membrane allows continual exchange 
between diffuse receptor populations and synaptic or extrasynaptic receptor clusters, 
with anchoring molecules tethering or corralling moving receptors. The synaptic 
localization of α2-containing GABAAR is maintained by direct binding to gephyrin, which 
binds to microtubules and actin interactors. Gephyrin also displays local lateral 
movements (indicated by the double-headed arrow) and removal or addition by 
microtubule-dependent trafficking. This traffic of gephyrin further contributes to the 
regulation of GABAergic synaptic transmission. The extrasynaptic localization of α5-
containing GABAAR is controlled by the binding of the α5 subunit to activated radixin, 
which directly binds F-actin. From (Jacob et al., 2008) 
 
1.2.2.4. Endocytosis of GABAAR from the plasma membrane  
The process of GABAAR endocytosis occurs mainly via clathrin- and 
dynamin-dependent mechanisms upon interaction of the GABAAR β and 
γ subunits with the AP2 clathrin adaptor protein complex (Kittler et al., 
2005; Kittler et al., 2008; Kittler et al., 2000). In one-week-old cultures 
GABAAR endocytosis occurs within 30 min for 25% of the receptors 
present in the membrane, and 70% of these receptors are recycled back 
to the cell surface within one hour. Six hours after internalization about 
30% of GABAAR are subjected to lysosomal degradation (Kittler et al., 
2004).  
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GABAAR are intimately associated with AP2 in the brain through a direct 
binding of the β1–3 and γ2 GABAAR subunits (Kittler et al., 2000). The 
first sequence motifs important for AP2/clathrin/dynamin-mediated 
endocytosis of GABAAR was identified in an heterologous system and 
correspond to a dileucine motif present in β subunits (Herring et al., 
2005; Herring et al., 2003). Additional studies performed in neurons 
identified a ten amino acid sequence motif (KTHLRRRSSQLK in the β3 
subunit) that includes a major phosphorylation site conserved in the 
cytoplasmic loop region of β1-3 subunits (S408, S409 in β3) as an 
important motif for AP2/clathrin/dynamin-mediated GABAAR 
internalization (Kittler et al., 2005; Kittler et al., 2008). This motif also 
contains the major sites of phosphorylation by cAMP-dependent protein 
kinase (PKA) and calcium/phospholipid-dependent protein kinase (PKC) 
within this class of receptor subunits: S409 in β1, S410 in β2, and 
S408/9 in β3 (Moss et al., 1995). The interaction of the AP2 μ2 subunit 
with GABAAR is negatively regulated by phosphorylation of GABAAR β 
subunits. In fact, AP2 binds GABAAR when this site is dephosphorylated 
triggering their internalization. More recently, a tyrosine-based AP2-μ2 
adaptin-binding motif (Y365GY367ECL) was indentified in the GABAAR γ2 
subunit, which is also conserved in the γ1 and γ3 subunits (Kittler et al., 
2008). These tyrosine residues are the major sites for phosphorylation by 
Fyn and Src kinases (Bogdanov et al., 2006; Jacob et al., 2005; 
Nishikawa et al., 2002). (Tab. 1.1) 
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TABLE 1. GABAAR phosphorylation sites. Adapted from (Vithlani et al., 2011) 
 
 
1.2.3. Post-endocytic GABAAR sorting 
Following internalization, GABAAR are rapidly recycled back to the 
neuronal plasma membrane or targeted for lysosomal degradation (Fig. 
1.7). The destiny of internalized receptors is determinant for surface 
receptor levels. 
1.2.4. Recycling of GABAAR 
The decision regarding the sorting of endocytosed GABAAR depends on 
the interaction of GABAAR β1-3 subunits with huntingtin-associated 
protein 1 (HAP1) (Fig. 1.7) (Kittler et al., 2004). HAP1 is a GABAAR‑
associated protein that binds the intracellular loop of β subunits in vitro 
and in vivo (Kittler et al., 2004). This protein is localized in the cytoplasm 
and contains several central coil ‑ coiled domains that are likely to 
regulate protein–protein interactions. Overexpression of HAP1 in neurons 
inhibits GABAAR degradation and consequently increases receptor 
recycling (Kittler et al., 2004). Furthermore, HAP1 overexpression was 
shown to increase surface levels of GABAAR and mIPSC amplitude (Kittler 
et al., 2004). An unanswered question is whether HAP1 promotes 
recycling of GABAARs or prevents their lysosomal degradation. 
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1.2.5. Degradation of GABAAR 
Endocytosed GABAAR that fail to be recycled are targeted for lysosomal 
degradation (Kittler et al., 2004). This process is regulated by 
ubiquitination of a series of lysine residues within the intracellular 
domain of the γ2 subunit. Accordingly, an increase of GABAAR 
accumulation at the synapses is observed when lysosomal activity is 
blocked or the trafficking of ubiquitinated cargo to lysosomes is disrupted 
(Arancibia-Carcamo et al., 2009). Studies performed in primary neuronal 
cultures showed a biphasic degradation of GABAAR, with about 42 % of 
the receptors displaying a short half-live of 3.8 hours, while the 
remaining 58% of the receptors show a half-life of 32 h (Borden and Farb, 
1988). The stability of the former pool of receptors is not affected by 
lysosomal inhibitors, indicating that they are degraded by a non-
lysosomal pathway. A surface biotinylation–degradation assay using 
cortical neuronal cultures, to assess the degradation of surface receptors, 
revealed that approximately 25 % of previously biotinylated surface 
receptors were degraded in 6 h and this effect was shown to be mediated 
by lysosomes (Kittler et al., 2004). In addition to the lysosomal system, a 
major mechanism for protein degradation involves the 26S proteasome, 
which promotes the degradation of polyubiquitinated substrates, a 
system largely recognized to play a role in the degradation of short-lived 
cytoplasmic proteins. Singly expressed to oligomeric structures formed by 
3 GABAAR subunits may be degraded quickly by the proteasome (Bedford 
et al., 2001), but it is unknown whether receptor subunits are 
polyubiquitinated. 
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FIGURE 1.7. GABAAR clathrin-mediated endocytosis.  
The receptors cluster in specialized sites at the plasma membrane known as clathrin-
coated pits, which invaginate and pinch off to form clathrin-coated vesicles (CCVs), a 
process that is dependent on dynamin. The clathrin adaptor protein (AP)-2 is a central 
component in the formation of these vesicles, forging a link between membrane proteins 
and clathrin that forms the outer layer of the coat. The vesicles subsequently lose their 
coat and fuse together to form an early endosome. Internalized receptors are then either 
subjected to rapid recycling or targeted for lysosomal degradation, an endocytic sorting 
decision that is regulated by the Huntingtin-associated protein (HAP)-1. From (Vithlani 
et al., 2011) 
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1.2.6. Pharmacology of GABAAR  
GABAAR are the site of action of diverse pharmacologically and clinically 
important drugs such as benzodiazepines, barbiturates, neuroactive 
steroids, anesthetics and convulsants, which allosterically modulate 
GABA-induced currents (Sieghart, 1995). The study of the activity of 
these drugs also contribute to elucidate the role of GABAAR in the 
modulation of anxiety, excitability of the brain, muscle tonus, vigilance, 
circadian rhythms, learning and memory (Ramerstorfer et al., 2011; 
Sieghart, 1995). 
The binding sites for GABA and for some allosteric modulators of 
GABAAR were already identified (Olsen and Sieghart, 2008). Two GABA 
binding sites are located at the two β+-α- interfaces in the extracellular 
region of GABAAR composed of 2α, 2β and one γ subunit (Smith and 
Olsen, 1995). The benzodiazepines bind to a site located at the α+ γ - 
interface (Ernst et al., 2003; Sigel and Buhr, 1997) but in contrast to 
GABA or GABA agonists they do not activate directly GABAAR. The high-
affinity benzodiazepine binding site modulates allosterically GABA-
induced currents. In fact, the transduction of benzodiazepine-induced 
conformational changes to the channel is less efficient as compared with 
GABA, in addition only a single high-affinity benzodiazepine binding site 
at the α+ γ – interface is present, which alone is not able to directly 
activate the channel in the absence of GABA. In contrast to the 
benzodiazepines allosteric modulation, steroids, inhalation anesthetics, 
i.v. anesthetics or barbiturates exhibit two different actions depending on 
the concentration. At low concentrations, they enhance GABA-induced 
currents, and at higher concentrations, they are able to directly provoke 
GABAAR-mediated currents in the absence of GABA (Sieghart, 1995). 
These compounds, thus, presumably interact with at least two binding 
sites at GABAAR.  
As mentioned before GABAARs exhibit an heterogeneous subunits 
composition with distinct but overlapping regional distribution in the 
brain. At the single cell level, there are cells expressing only a few 
GABAAR subunits, and others expressing most of these subunits (Pirker 
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et al., 2000; Wisden et al., 1992); giving rise to a multiplicity of these 
receptors. Moreover individual receptor subtypes often have a quite 
specific regional, cellular and subcellular distribution. (Kasugai et al., 
2010; Nusser et al., 1998b) (Brunig et al., 2002; Crestani et al., 2002; 
Farrant and Nusser, 2005). A distinct subunits composition and 
distribution of receptor subtypes also suggests a distinct function. From 
a pharmacological point of view studies performed in transgenic mice, 
indicates that GABAARs containing α1 subunits seem to be involved in 
the sedative, anticonvulsant and anterograde amnestic actions of 
diazepam (McKernan et al., 2000; Rudolph et al., 1999). Similar 
experiments indicate that receptors containing α2 subunits primarily 
mediate the anxiolytic effects of diazepam (Low et al., 2000), and the 
analgesic action of local diazepam in the spinal cord (Knabl et al., 2008). 
Steroids seem to preferentially modulate receptors containing the δ 
subunit (Hosie et al., 2009; McKernan et al., 2000; Stell et al., 2003); 
these and other studies for the first time indicated a possible function of 
specific GABAAR subtypes in the rodent brain.  
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1.3. EFFECTS OF ISCHEMIA ON GABA NEUROTRANSMISSION 
The insufficient blood supply to the brain during cerebral ischemia leads 
to excitotoxic neuronal death. This pathological condition is characterized 
by an unbalance between excitatory/inhibitory neurotransmission which 
contributes to neuronal damage (Choi, 1992; Lipton, 1999). In the CNS 
this balance is mainly regulated by glutamatergic and GABAergic 
neurotransmission, which are respectively up- and downregulated during 
ischemic insults. While the role of glutamate in neuronal death in brain 
ischemia is well documented, the alterations in GABAergic 
neurotransmission have received little attention and are not as well 
characterized. The experimental evidence presently available, using in 
vivo and in vitro models, point to alterations in GABAergic synaptic 
transmission in brain ischemia, both at the pre- and post-synaptic levels. 
Brain ischemia has been shown to induce an extracellular accumulation 
of GABA, which may be due to: i) an increase in Ca2+-dependent release 
of the neurotransmitter before depletion of ATP, which is required for 
exocytosis; ii) reversal of GABA transporters induced by plasma 
membrane depolarization and changes in the Na+ electrochemical 
gradient; and iii) the leakage of GABA from injured, permeable terminals 
(Hutchinson et al., 2002; Phillis et al., 1994). However, in the case of 
transient cerebral ischemia, the extracellular levels of GABA return to 
normal within one hour of the reperfusion onset (Globus et al., 1991; 
Inglefield et al., 1995; Phillis et al., 1994; Schwartz et al., 1995). 
Interestingly previous results from our lab shown that excitotoxic 
conditions lead to the cleavage of glutamic acid decarboxylase (GAD) in 
cultured hippocampal neurons in a UPS-dependent manner (Baptista et 
al., 2010). GAD is the key enzyme in the synthesis of GABA (Martin and 
Rimvall, 1993) and was already known to be cleaved in cerebrocortical 
neurons subjected to excitotoxic conditions by a mechanism that is 
sensitive to inhibitors of calpain (Sha et al., 2008) (Monnerie and Le 
Roux, 2007). Cleavage of GAD diminished the activity of the enzyme and 
changed the its subcellular distribution (Baptista et al., 2010), which 
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should decrease GABA production and may affect the accumulation of 
the neurotransmitter in synaptic vesicles. Moreover under excitotoxic 
conditions also the GABA vesicular transporter VGAT is cleaved in a 
calpain dependent manner gives rise to a truncated form of the 
transporter (tVGAT) (Gomes et al., 2011). These aspects are expected to 
decrease the release of GABA by exocytosis under excitotoxicity Therefore 
the extracellular accumulation of the neurotransmitter likely does not 
depend by an increased of the GABA exocytose  
This large accumulation of extracellular GABA can have several 
functional consequences despite being transient. For example, 
extracellular accumulation of GABA down-regulates GABA synthesis 
transiently, as shown in the mouse neocortex following a permanent 
middle cerebral artery occlusion (Green et al., 1992), and can induce 
adaptations in GABAAR and changes in the Cl- gradient. In fact, 
sustained exposure of receptors to high concentrations of agonists 
usually leads to receptor down-regulation and there is evidence that this 
may happen in vivo, after transient cerebral ischemia. In gerbils 
subjected to transient global ischemia, GABAAR are down-regulated in 
the hippocampus and cerebral cortex within 30 min of the onset of 
reperfusion, when GABA levels have started to normalize (Alicke and 
Schwartz-Bloom, 1995).  
The effects of in vivo and in vitro ischemia on GABAAR function have 
been assessed mainly by electrophysiology, optical imaging of 
intracellular Cl- changes and Cl--flux assays. Electrophysiological studies 
showed that GABA-induced inhibitory postsynaptic potentials (IPSPs) 
disappear earlier than excitatory postsynaptic potentials (EPSPs) (Xu and 
Pulsinelli, 1994). Similar findings were reported in hippocampal slice 
preparations exposed to anoxia in vitro (Congar et al., 1995). Also, during 
reperfusion GABAAR response results are attenuated. In forebrain 
synaptoneurosomes, a subcellular fraction containing the pre- and post-
synaptic regions, GABA-gated Cl--flux is reduced during the first 2 h after 
cerebral ischemia (Verheul et al., 1993). Optical imaging of the 
hippocampal slice also showed that GABAAR responses in area CA1 
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pyramidal neurons are reduced early after the onset of reoxygenation 
(Inglefield and Schwartz-Bloom, 1998). A reduction in GABAA currents 
was also observed in cultured hippocampal neurons subjected to OGD, 
and this effect was attributed to the depletion of ATP and to an increase 
in intracellular Ca2+ (Harata et al., 1997). 
The ischemia-induced alterations that decrease GABAAR activity 
comprise two major types of postsynaptic cellular events: the reduction in 
the transmembrane Cl- gradient and the production of cellular mediators 
that alter GABAAR and their functional responses. There are indeed 
evidences pointing to an increase in the intracellular Cl- concentration in 
adult neurons following oxygen-glucose deprivation as well as in in vitro 
cerebral ischemia. Thus, in hippocampal slices deprived of oxygen and 
glucose, an increase in intracellular Cl- was observed in cell bodies at the 
CA1 area (Taylor et al., 1995). Furthermore, intracellular Cl- was shown 
to increase in CA1 pyramidal neurons and in interneurons early after the 
onset of reoxygenation (Inglefield and Schwartz-Bloom, 1998). In 
accordance with these results, reduced GABAA responses in CA1 
pyramidal neurons are observed following the rise in intracellular Cl- 
induced by oxygen-glucose deprivation (Inglefield and Schwartz-Bloom, 
1998). These in vitro results are supported by in vivo studies showing 
that focal cerebral ischemia reduces the GABA-mediated inhibition 
through a depolarizing shift in the reversal potential for GABAA-mediated 
IPSPs in the primary somatosensory cortex (Mittmann et al., 1998). 
Anoxia was also found to suppress GABA-mediated IPSCs in 
hippocampal slices due to a positive shift in ECl- (Mittmann et al., 1998).  
There are several possible mechanisms by which cerebral ischemia 
increases the intracellular Cl- concentration, including the passive influx 
together the influx of Na+, influx through GABA-gated Cl- channels, 
inhibition of the voltage-gated Cl- channel (ClC-2), hypofunction or 
reversal of outward Cl- cotransporters and activation of inward Cl- 
cotransporters. Studies demonstrate that oxygen-glucose deprivation 
causes an ATP-dependent rundown of GABAA currents in hippocampal 
neurons (Harata et al., 1997), suggesting that the Cl- ATPase fails to 
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transport Cl- into the extracellular space early during reperfusion, when 
ATP levels are still very low. 
GABAAR function, similarly to glutamate receptors, may also be 
modulated by cellular signals generated during cerebral ischemia. Firstly, 
an increased intracellular Ca2+ concentration decreases GABA-gated Cl- 
conductance (Inoue et al., 1986; Stelzer et al., 1988) and GABA-induced 
currents in neuronal cultures (Llano et al., 1991; Martina et al., 1994). 
One of the Ca2+-dependent enzymes activated by ischemia is 
phospholipase A2, which generates arachidonic acid from the hydrolysis 
of membrane phospholipids. It was shown that phospholipase A2, 
arachidonic acid and its metabolites (i.e. prostaglandins and 
thromboxanes) decrease GABAA responses in cerebral cortical 
synaptoneurosomes (Schwartz-Bloom et al., 1996; Schwartz et al., 1988; 
Schwartz and Yu, 1992). In addition, there are several studies 
demonstrating the sensitivity of GABAA neurotransmission to oxidative 
stress. Generation of superoxide radicals inhibits GABAA responses in 
cerebral cortical synaptoneurosomes in a Ca2+-dependent manner 
(Schwartz et al., 1988). In addition, the generation of superoxide radicals 
and H2O2 have direct effects on GABAAR, decreasing the maximal density 
of Cl- channel sites in brain homogenates (Sah et al., 2002). Exposure of 
hippocampal (Pellmar, 1995) and thalamocortical slices (Frantseva et al., 
1998) to H2O2 also reduced significantly the inhibitory postsynaptic 
potentials (IPSPs).  
The down-regulation of GABAergic synapses in brain ischemia may also 
result from the reduction of GABAAR phosphorylation which leads to 
receptor desensitization (Gyenes et al., 1994) and a reduction of cell 
surface density of GABAAR (Nusser et al., 1997; Nusser et al., 1998a). 
These receptors, similarly to most plasma membrane proteins, are very 
dynamic at neuronal cell surface, not only for their cycle between the 
plasma membrane and intracellular compartments, but also for lateral 
diffusion (see section 1.2.2.3). The lateral diffusion of GABAAR has 
recently gained increased importance following the observations showing 
that the receptors are inserted into and removed from the plasma 
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membrane exclusively at extrasynaptic sites (Bogdanov et al., 2006; 
Thomas et al., 2005). Therefore, the key mechanism controlling the size 
of the GABAAR postsynaptic pool, thereby accounting for the strength of 
inhibitory synapses, is the receptor exo- and endocytosis. Several studies 
have reported a decrease in the surface and synaptic GABAAR expression 
during ischemia, suggesting an increase in receptor endocytosis 
(Arancibia-Carcamo and Kittler, 2009; Liu et al., 2010; Mielke and Wang, 
2005; Zhan et al., 2006). In vitro studies, using cell culture ELISA as a 
cell surface receptor assay, showed that OGD decreases cell surface 
GABAAR in cultured cortical neurons without altering the total amount of 
receptors. Inhibition of receptor endocytosis with hypertonic sucrose 
treatment prevented receptor internalization and similar results were 
obtained in cells treated with insulin. Under the latter conditions the 
cells were protected from OGD-induced cell death, and the authors 
suggested that GABAAR internalization contributes to neuronal death 
(Mielke and Wang, 2005). This hypothesis was later supported in studies 
using the same technique to follow receptor internalization in addition to 
the biotinylation assay. In this set of experiments the activation of 
phosphatidylinositol 3-kinase/Akt–dependent signaling pathway, 
through PTEN downregulation, was shown to protect neurons from the 
toxic effects of OGD by preventing the reduction in the surface expression 
of GABAAR (Liu et al., 2010). More recently, it was shown that the 
downmodulation of GABAARs from dendritic clusters during OGD is 
dependent on the AP2 pathway for cell surface removal of the receptors. 
Moreover, blockade of this pathway reduced the neuronal death induced 
by OGD (Smith et al., 2012). Although these findings point to a key role 
of GABAAR endocytosis in OGD-induced downmodulation of GABAergic 
neurotransmission and cell death the strategy employed may also 
interfere with the internalization of other proteins mediate by the AP2 
pathway. The hypothesis that the reduction of surface GABAAR is 
accompanied by alteration of the GABAAR subunits was not much 
investigated however as shown that in vivo ischemia there is a loss of 
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GABAAR subunit mRNA expression in hippocampal neurons before the 
degeneration of CA1 pyramidal cells (Li et al., 1993). 
 
1.3.1. Neuroprotection by GABAergic drugs after cerebral ischemia 
Considering the evidence for the alteration in GABAergic 
neurotransmission in ischemia, and its role in neuronal death, the 
GABAergic system is an obvious target for neuroprotection studies. The 
upregulation of the GABAergic system as a neuroprotective strategy can 
be achieved by acting at different levels, using GABA agonists, GABA 
modulators, GABA transporter inhibitors and GABA transaminase 
inhibitors. 
Injection of the benzodiazepine diazepam directly into area CA1 of the 
hippocampus was shown to be neuroprotective (Schwartz et al., 1995). 
Also, the GABA modulator chlomethiazole reduces cerebral cortical and 
striatal infarct size in rats and marmosets when administered 1 h after 
occlusion of the middle cerebral artery (Green et al., 2000; Marshall et 
al., 2000; Sydserff et al., 1995).  
In general the therapeutic window of GABAergic drugs is relatively short 
(Cross et al., 1991; Hall et al., 1997; Inglefield et al., 1995; Schwartz-
Bloom et al., 1998; Schwartz-Bloom et al., 2000; Schwartz et al., 1994; 
Schwartz et al., 1995; Shuaib et al., 1995). For example, the 
benzodiazepine partial agonist imidazenil and the GABA uptake inhibitor 
tiagabine were shown to be neuroprotective in CA1 hippocampal neurons 
when the effects were evaluated 4-7 days after transient global ischemia, 
but not 21-35 days after ischemia (Inglefield et al., 1995; Schwartz-
Bloom et al., 1998). Independently of the strategy used, the current 
model postulates that to be effective neuroprotective drugs need to be 
administered early, within a few hours of a stroke (De Keyser et al., 
1999). 
Despite the neuroprotective effects of GABAAR agonists (e.g. 
clomethiazole) in both global and focal ischemia models, as shown by 
various outcome measures such as histopathology, excitatory amino acid 
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release in vivo, and edema formation (Green, 1998), clinical trials failed 
to confirm its benefit. (Lyden et al., 2001). Diazepam was also 
investigated in clinical trials, in the search for a potential neuroprotective 
effect in acute stroke, with the treatment initiated within 12 h from 
onset, but no significant effects were obtained (Lodder et al., 2006). The 
negative outcomes of GABAergic drugs in the treatment of cerebral 
ischemia suggest that the activation of GABAAR may not be the better 
strategy to upregulate GABAergic transmission in this pathologic 
condition. 
 
 
  
60 
 
 
 
 
 
 
 
 
 
 
 
 
 61 
OBJECTIVES  
GABAA receptors (GABAAR) are the main mediators of inhibitory 
neurotransmission in the CNS and play an essential role in maintaining 
the excitatory/inhibitory balance required for the correct function of 
neuronal networks (Smith and Kittler, 2010). Modulation of GABAAR 
expression at the synapse plays a key role in determining the strength of 
synaptic inhibition (Arancibia-Carcamo and Kittler, 2009). In brain 
ischemia the surface downmodulation of GABAAR contributes to 
compromise neuronal inhibition thereby altering neuronal excitability, 
but the molecular mechanisms underlying the changes in the GABAAR 
surface expression under pathological conditions remain poorly 
understood. 
The present work was aimed at investigating the molecular mechanisms 
underlying GABAAR downregulation in cultured hippocampal neurons 
subjected to Oxygen Glucose Deprivation (OGD), an in vitro model of 
ischemia. More specifically we investigated the effect of transient 
exposure of hippocampal neurons to OGD on: 
 
 the total protein levels of GABAAR subunits characteristic of 
synaptic (α1, α2, β3, γ2) and extrasynaptic (δ subunit) receptors. 
The role of calpains in the alterations of GABAAR total protein 
levels was also investigated; 
 
 the expression levels of α1, α2, β2, β3 and γ2 GABAAR subunits, 
and the contribution of glutamate receptor activation, using 
quantitative PCR experiments;  
 
 the internalization of GABAAR. In particular we studied the effect of 
OGD on i) GABAAR/Gephyrin interaction, using a surface co-
immunoprecipitation assay, and on ii) the internalization of 
GABAAR via clathrin dependent endocytosis, using a antibody-
feeding assay;  
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 the dephosphorylation and internalization of β3 GABAAR subunits, 
and the contribution of dephosphorylation and consequent 
internalization of the receptors to neuronal cell death. The role of 
receptor phosphorylation in OGD-induced neuronal death was 
investigated using a phospho-mutant form of the β3 GABAAR 
subunit; 
 
 the recycling of GABAAR back to the plasma membrane and their 
interaction with the HAP1, the protein that determines the sorting 
of endocytosed GABAAR. 
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2.1. Hippocampal cultures  
Primary cultures of rat hippocampal neurons were prepared from the 
hippocampi of E18-E19 Wistar rat embryos, after treatment with trypsin 
(0.06%, 15 min, 37°C; GIBCO Invitrogen) in Ca2+- and Mg2+-free Hank’s 
balanced salt solution (HBSS; 5.36 mM KCl, 0.44 mM KH2PO4, 137 mM 
NaCl, 4.16 mM NaHCO3, 0.34 mM Na2HPO4.2H2O, 5 mM glucose, 1 mM 
sodium pyruvate, 10 mM HEPES and 0.001% phenol red). The 
hippocampi were then washed with HBSS containing 10% fetal bovine 
serum (GIBCO Invitrogen), to stop trypsin activity, and transferred to 
Neurobasal medium (GIBCO Invitrogen) supplemented with B27 
supplement (1:50 dilution; GIBCO Invitrogen), 25 μM glutamate, 0.5 mM 
glutamine and 0.12 mg/ml gentamycin. The cells were dissociated in this 
solution and were then plated on 6 well plates (90.0x103 cells/cm2), 
previously coated with poly-D-lysine (0.1 mg/mL), or on poly-D-lysine 
coated glass coverslips, at a density of 80.0x103 cells/cm2. The cultures 
were maintained in a humidified incubator with 5% CO2/95% air, at 
37°C, for 15 days. 
 
2.2. Oxygen-glucose deprivation 
Hippocampal neurons (15 DIV) were incubated in a glucose-free saline 
buffer (116 mM NaCl, 25 mM sucrose, 10 mM HEPES, 5.4 mM KCl, 0.8 
mM MgSO4, 1 mM NaH2PO4, 1.8 mM CaCl2, 25 mM NaHCO3) in an 
anaerobic chamber with 10% H2, 85% N2, 5% CO2 (Forma Anaerobic 
System, Thermo Fisher Scientific), at 37°C, for the indicated period of 
time. The OGD buffer was then replaced by conditioned medium and the 
cultures were returned to the humidified 95% air/5% CO2 incubator for 
the indicated post-incubation time period. Under control conditions 
(Sham) the cells were incubated in the saline buffer described above, 
supplemented with 25 mM glucose instead of sucrose, and kept in the 
humidified 95% air/5% CO2 incubator at 37°C. When appropriate the 
cells were pre-incubated with glutamate receptor or calpain inhibitors (20 
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µM NBQX [Tocris] and 100 µM APV [Tocris] were added 30 min before 
OGD; 50 µM ALLN [Calbiochem] or 50 µM MDL28170 [Calbiochem], 1 h 
before OGD), and the drugs were also present during and after the insult. 
 
2.3. Nuclear morphology analysis 
After OGD followed by incubation in culture conditioned medium, 
neurons were fixed in 4% sucrose/paraformaldehyde and incubated with 
the fluorescent dye Hoechst 33342 (1 μg/ml) for 10 min. The coverslips 
were then mounted on a slide with a fluorescence mounting medium 
(DAKO), and imaging was performed on a Zeiss Axiovert 200 fluorescence 
microscope coupled to an Axiocam HRm digital camera. For each 
experimental condition three coverslips were analyzed (at least 200 cells 
per coverslip were counted), and at least three independent experiments 
were performed, using distinct preparations. 
 
2.4. Western blotting  
Total cell extracts were prepared after washing the cells twice with ice-
cold PBS buffer. The cells were lysed with RIPA buffer (150 mM NaCl, 50 
mM Tris-HCl, 5 mM EGTA, 1% Triton, 0.5% DOC and 0.1% SDS, at a 
final pH 7.5) supplemented with 1 mM DTT and a cocktail of protease 
inhibitors (0.1 mM PMSF, 1 μg/ml chymostatin, 1 μg/ml leupeptin, 1 
μg/ml antipain, 1 μg/ml pepstatin; Sigma-Aldrich Química). For 
phosphorylation studies the lysis buffer was contained 10 mM HEPES, 
150 mM NaCl, 10 mM EDTA and 1% Triton (pH 7.4), and was 
supplemented with phosphatase inhibitors (50 mM NaF and 1.5 mM 
sodium orthovanadate). After centrifugation at 16,100x g for 10 min, 
protein levels present in the supernatants were quantified using the BCA 
method (Thermo Scientific). Samples were then diluted with a 2x 
concentrated denaturing buffer (125 mM Tris, pH 6.8, 100 mM glycine, 
4% SDS, 200 mM DTT, 40% glycerol, 3 mM sodium orthovanadate, and 
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0.01% bromophenol blue). Protein samples were separated by SDS-
PAGE, in 10% polyacrylamide gels, transferred to PVDF membranes 
(Millipore) and immunoblotted. Membranes were incubated with primary 
antibodies (overnight at 4°C), washed and exposed to alkaline 
phosphatase-conjugated secondary antibodies (1:20,000 dilution; 1h at 
room temperature) (GE Healthcare or Jackson ImmunoResearch). 
Alkaline phosphatase activity was visualized using ECF on the Storm 860 
Gel and Blot Imaging System (GE Healthcare). The following primary 
antibodies were used: anti-Alpha1 GABAA receptor (1:1000, NeuroMab), 
anti-Alpha2 GABAA receptor (1:1000, Synaptic System), anti-Beta 3 
GABAA receptor (1:1000, NeuroMab), anti-Phospho-Ser408/409 Beta 3 
GABAA receptor (1:1000, Symansis), anti-Gama 2 GABAA receptor 
(1:1000, Synaptic Systems) and anti-Gephyrin (1:1000, Synaptic 
Systems). Anti-Synaptophysin (1:10000, Abcam) and anti-β-tubulin 
(1:300000, Sigma) antibodies were used as loading controls. 
Dephosphorylation of the lysate proteins was performed by incubating 30 
μg of protein with 1 μl of λ protein phosphatase (Final concentrations: 
~20 U/ml; New England BioLabs), in 1x NEBuffer supplemented with 1 
mM MnCl2, for 1 h at 30°C. Samples were then diluted with a 2x 
concentrated denaturing buffer and the proteins were separated by SDS-
PAGE as described above. 
 
2.5. q-PCR Analyses 
2.5.1.  Total RNA isolation, RNA quality and RNA concentration  
Total RNA extraction from cultured hippocampal neurons was performed 
with TRIzol (Invitrogen). Briefly, 1mL of TRIzol was added to each well 
(density of 90.0x103 cells/cm2) of a 6-well cluster plate and the content of 
each experimental condition (two wells) was collected. Chloroform was 
then added for phase separation and the RNA was precipitated by 
isopropanol addition. The precipitated RNA was washed with 75% 
ethanol, centrifuged, air-dried and resuspended in 20 µl of RNase-free 
water (GIBCO Invitrogen). RNA quality and integrity was evaluated using 
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the Experion automated gel-electrophoresis system (Bio-Rad). RNA 
concentration was determined using a NanoDrop 2000c/2000 UV-Vis 
Spectrophotomer (Thermo scientific). The samples were stored at -80°C 
until further use. 
2.5.2. Reverse transcription reaction  
First strand cDNA was synthesized from 1 µg of total RNA using iScript 
cDNA synthesis kit (Bio-Rad) following the manufacturer’s specifications. 
2.5.3. Primer design  
Primers for real-time PCR were designed using the “Beacon Designer 7” 
software (Premier Biosoft International), with the following specification: 
(1) GC content about 50%; (2) Annealing temperature (Ta) between 55 ± 
5°C; (3) Secondary structures and primer-dimers were avoided; (4) Primer 
length between 18-24 bp; (5) Final product length between 100-200 bp. 
2.5.4. Real-Time PCR  
Gene expression analysis was performed using SsoFastTM SuperMix (Bio-
Rad). Briefly, 2 µl of 1:10 diluted cDNA were added to 10 µl of 2x 
EvaGreen and to specific primers (final concentration of each was 250 
nM in 20 µl total volume). The thermocycling reaction was composed of 
the following steps: 1) activation of the Sso7d fusion DNA polymerase 
(95°C for 30 s), 2) denaturation (45 cycles of a 10s step at 95°C), 3) 
annealing (30 s at the optimal annealing temperature for each set of 
primers) and 4) elongation (30s at 72°C). At the end of the thermocycling 
reaction a melting step was performed (starting at 55°C with a rate of 
0.5°C per 10 s, up to 95°C). The fluorescence was measured after the 
extension step, using the iQ5 Multicolor Real-Time PCR Detection System 
(BioRad). To calculate the efficiency of each set of primers all assay 
included a non-template control and a standard curve of cDNA. The 
reactions were run in duplicate. The value used for the quantification 
was the threshold cycle (Ct; the detectable fluorescence signal above 
background resulting from the accumulation of amplified product), a 
CHAPTER 2 – Material and Methods 
69 
value that is a proportional measure of the starting concentration of the 
target sequence. The threshold base line was always set at the beginning 
of the exponential phase. Data analysis was performed using the GenEx 
(MultiD Analyses) software for Real-Time PCR expression profiling. 
 
2.6. Fluorescence assay of receptor internalization 
Cultured living hippocampal neurons (15 DIV) were incubated at RT for 
10 min in the presence of a high concentration (1:100) of an anti-Alpha1 
GABAA receptor antibody (Millipore), directed against the N-terminus of 
the α1 subunits, or an anti-myc antibody (1:300, Cell Signaling). The 
cells were then washed with PBS at 37°C, to remove the unbound 
antibody, and were further incubated in an antibody free conditioned 
medium at the same temperature (for different periods) to allow the 
internalization of antibody-bound receptors. After this incubation 
neurons were fixed for 15 min in 4% sucrose/paraformaldehyde. Next, 
neurons were exposed to a super-saturating concentration (1:300) of the 
first of two secondary antibodies (Alexa Fluor 488 goat anti-rabbit; 
Invitrogen) for 1h at RT. After permeabilization (0.25% Triton X-100 for 5 
min) the cells were incubated with the second secondary antibody (Alexa 
Fluor 568 goat anti-rabbit, 1:500 Invitrogen) for 1 h at RT. This strategy 
allows distinguishing the surface receptors from those receptors that 
have been internalized before fixation (Goodkin et al., 2005). The 
coverslips were then mounted on slides with a fluorescence mounting 
medium (DAKO). Images were acquired on Axio Observer 2.1 fluorescence 
microscope (Zeiss) coupled to an Axiocam HRm digital camera, using a 
63x oil obective and were quantified using the ImageJ image analysis 
software. For each experiment analyzed the cells were stained and 
imaged using identical settings. The ratio of internalization was 
calculated using the internalized antibody signal/total antibody signal 
ratio (Fig. 2.1). 
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FIGURE 2.1. Schematic representation of the fluorescence assay used to assess 
receptor internalization. 
 
2.7. Immunocytochemistry 
Hippocampal neurons were fixed in 4% sucrose/paraformaldehyde (in 
PBS) and permeabilized with 0.3% Triton X-100 in PBS. The neurons 
were than incubated with 10% BSA in PBS for 30 min at 37°C, and 
incubated with the primary antibody anti-myc (1:500, Cell Signaling) 
diluted in 3% BSA in PBS, overnight at 4°C. The cells were washed with 
PBS and incubated with the secondary antibody (anti-mouse IgG) 
conjugated with Alexa Fluor 488 (Invitrogen), for 1 h at RT. The 
coverslips were mounted in a fluorescence mounting medium (DAKO, 
Denmark). Imaging was performed in an Axio Observer 2.1 fluorescence 
microscope, coupled to an Axiocam HRm digital camera, using a 63x oil 
objective. The cells to count were chosen by the myc (green) channel to 
check for the presence of transfected neurons. Measurements were 
performed in three independent preparations, and at least 50 cells were 
counted per experimental condition for each preparation.  
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2.8. Surface co-immunoprecipitation assay 
After stimulation using the indicated experimental conditions 
hippocampal neurons were washed twice with ice-cold PBS and 
incubated with Sulfo-NHS–SS–biotin (0.25 mg/ml in PBS; Thermo 
Scientific) for 15 min on ice. Cells were then washed twice with 50 mM 
NH4Cl and two times more with PBS. After biotinylation, the cells were 
lysed with RIPA buffer and α1-containing GABAARs were 
immunoprecipitated. 
Protein G Plus-Agarose beads (50 μl; Santa Cruz Biotechnology) were 
added to Lysis buffer (1 ml) containing 5 μg of an anti-GABAAR alpha 1 
subunit (NeuroMab) monoclonal antibody and incubated for 2 h on a 
head-over-head shaker at 4°C. Antibody excess was removed by two 
rinses with lysis buffer. Lysed samples (400 μg) were added to the beads 
and incubated for 6 h on a head-over-head shaker at 4°C. Beads were 
centrifuged at 800× g to remove the antibody, and the samples were then 
washed three times with lysis buffer. The residual buffer was removed 
and bead–IP–GABAARs were incubated with 50 μL of 1% SDS (80 min at 
37°C) to disrupt the interaction between the beads and IP-GABAARs. 
Finally, beads were centrifuged at 800× g, and the supernatants were 
mixed with 150 μl of lysis buffer before being used in NeutAvidin pull-
downs. 
NeutAvidin® Plus UltraLink Resin beads (40 μL; Thermo scientific) were 
added to the samples and mixed on a head-over-head shaker for 4 h. 
Beads were then centrifuged at 800× g and washed three times with lysis 
buffer. The residual lysis buffer was removed and then 60 μL of 2× 
loading buffer was added. Samples were heated at 90°C for 5 min and 
beads were centrifuged at 800× g. The bead supernatants were used for 
western blot analysis (Fig. 2.2). 
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FIGURE 2.2. Schematic representation of the surface co-immunoprecipitation 
assay. 
 
2.9. Neuron transfection with calcium phosphate  
Transfection of cultured hippocampal neurons with myc-huGABAAR β3 
(WT), myc-huGABAAR β3 (p-mimetic) or myc-huGABAAR β3 (p-null) 
constructs was performed by the calcium phosphate coprecipitation 
method. Briefly, 2 μg of plasmid DNA were diluted in Tris-EDTA (TE) pH 
7.3 and mixed with 2.5 M CaCl2. This DNA/TE/calcium mix was added 
to 10 mM HEPES-buffered saline solution (270 mM NaCl, 10 mM KCl, 
1.4 mM Na2 HPO4, 11 mM dextrose, 42 mM HEPES, pH 7.2). The 
precipitates were allowed to form for 30 min at room temperature, 
protected from light, with vortex mixing every 5 min, to ensure that the 
precipitates had similar small sizes. Meanwhile, cultured hippocampal 
neurons were incubated with cultured-conditioned medium with 2 mM 
kynurenic acid (Sigma). The precipitates were added drop-wise to each 
well and incubated for 2 h at 37°C, in an incubator with 95% air/ 5% 
CO2. The cells were then washed with acidic 10% CO2 equilibrated 
culture medium containing 2 mM kynurenic acid and returned to the 
95% air /5% CO2 incubator for 20 min at 37°C. Finally, the medium was 
replaced with the initial culture-conditioned medium, and the cells were 
further incubated in a 95% air /5% CO2 incubator for 48 h at 37°C to 
allow protein expression. Cell cultures were then subjected to OGD for 90 
min, and 8 h after the insult the cells were fixed to proceed with the cell 
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death assay. In the case of the fluorescence internalization assay cells 
were subjected to 70 min of OGD. 
 
2.10. Mutagenesis 
The plasmid containing the human WT GABAAR β3 subunit sequence 
was a kind offer of Doctor Martin Wallner (Department of Molecular and 
Medical Pharmacology, David Geffen School of Medicine, UCLA). In the 
same vector, two myc-Tag sequences 
(GAGCAGAAGCTGATCTCAGAGGAGGATCTGGAGC 
AGAAGCTGATCTCAGAGGAGGATCTG) were added between the 4th and 
5th codon of human GABAAR β3 cDNA that code for the amino acids 
belonging to the N-terminus of the protein (NZYTech, Lda). To obtain the 
phospho-mimetic and a phospho-null mutants of the human GABAAR β3 
subunit, we performed a site directed mutagenesis of the serine residues 
432/433 (homologous of mouse 408/409), using QuikChange® II XL Site–
Directed Mutagenesis Kit (Agilent Technology). Briefly, specific primers 
were designed to mutate the two serine residues to two aspartate 
residues (5’ 
gcacaagaagacccatctacggaggagggatgatcagctcaaaattaaaatacctgatctaac3’), in 
the case of the phospho-mimetic mutant, and to two alanine residues (5’ 
gacccatctacggaggagggctgcacagctcaaaattaaaat 3’) in the case of the 
phospho-null mutant (primers were synthesized by Sigma Aldrich). For 
each mutagenesis the reaction contained 13.5 ng of dsDNA template 
(myc-huGABAAR β3), 5 µl of 10x reaction buffer, 125 ng of each 
oligonucleotide primer, 1 µl of dNTP mix, 3 µl of QuikSolution, ddH2O to 
final volume of 50 µl and 1 µl of PfuUltra HF DNA polymerase (2.5 U/µl). 
The following thermal cycling was then performed: 95°C for 1 min, 18 
cycles ( 95°C for 50 s, 60°C for 50 s, 68°C for 6 min 30 s ) and 68°C for 7 
min. The parental methylated dsDNA was then digested using 1 µl of Dpn 
I enzyme (New England BioLabs) at 37°C for 1 h. Dpn I digested dsDNA 
was used to transform E. coli Top 10 cells to be then amplified. The 
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obtained plasmid DNA was extracted using Plasmid Mini Kit (Quiagen) 
and sequenced to confirm the mutagenesis (STABvida). 
 
2.11. Middle cerebral artery occlusion 
Focal cerebral ischemia was induced by the transient occlusion of the 
right middle cerebral artery (MCA), using the intraluminal filament 
placement technique as described previously (Nygren and Wieloch, 2005). 
Briefly, adult male mice were anesthetized by inhalation of 2.5% 
isoflurane (IsobaVet, Schering-Plough Animal Health) in O2:N2O (30:70). 
Anesthesia was subsequently reduced to 1.5–1.8% isoflurane and 
sustained throughout the occlusion period. Body temperature was kept 
at ~37°C throughout the surgery period. To monitor regional cerebral 
blood flow (rCBF), an optical fiber probe (Probe 318-I, Perimed) was fixed 
to the skull at 2 mm posterior and 4 mm lateral to bregma and connected 
to a laser Doppler flow meter (Periflux System 5000, Perimed). A filament 
composed of 6 – 0 polydioxanone suture (PSD II, Ethicon) with a silicone 
tip (diameter of 225–275 μm) was inserted into the external carotid artery 
and advanced into the common carotid artery. The filament was 
retracted, moved into the internal carotid artery, and advanced until the 
origin of the MCA, given by the sudden drop in rCBF (~70% of baseline). 
After 45 min, the filament was withdrawn and reperfusion observed. The 
animals were placed in a heating box at 37°C for the first 2 h after 
surgery and thereafter transferred into a heating box at 35°C, to avoid 
postsurgical hypothermia. Thirty minutes and 24 h after the onset of 
reperfusion, 0.5 ml of 5% glucose was administered subcutaneously. 
Temperature and sensorimotor deficits were assessed at 1, 2 h and 24 h 
after the surgery. Body weight was controlled daily. In sham surgeries, 
the filament was advanced up to the internal carotid artery, and 
withdrawn before reaching the MCA. The Ethics Committee for Animal 
Research at Lund University approved animal housing conditions, 
handling, and surgical procedures. Eleven to 36 weeks old C57BL/6J 
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male mice (weight: 23.0 g to 37.9 g; Lund University breeding facility) 
were housed under diurnal conditions with ad libitum access to water 
and food before and after surgery.  
Mice were anesthetized 48 h after MCA occlusion (MCAO) or sham 
surgery, by inhalation of 2.5 % isoflurane and were then perfused 
transcardially with 0.9 % NaCl for 2 min before decapitation. Upon 
removal of meninges, brains were rapidly isolated and frozen by 
immersion in isopentane at -40°C, further cooled down to -70°C and 
stored at -80°C. The infarct core and remaining ipsilateral tissue 
(designated as penumbra for simplification) were dissected, as well as the 
contralateral cortex, from coronal brain sections covering the majority of 
damage. More specifically, consecutive 2 mm, 1 mm and 2 mm thick 
brain sections were made, starting at 2 mm from the olfactory bulb. 
Dissections were performed at -15 ºC, a temperature that allows an easy 
detachment of the infarct core and penumbra. The cortical-striatal 
infarcts obtained were illustrated in (Inacio et al., 2011). Equivalent brain 
regions were dissected from sham-operated mice, which were also 
designated as infarct core and penumbra, and contralateral cortex. For 
each animal, corresponding regions from each of 3 consecutive brain 
sections were pulled together. Samples were then homogenized and 
processed for Western blotting as previously described (Inacio et al., 
2011). Cellular protein extraction was performed by mechanical 
homogenization of the tissue and incubation in lysis buffer: 20 mM Tris 
(pH 7.5), 150 mM NaCl, 1mM EDTA, 1 mM EGTA, 1% Triton-X100, 2.5 
mM sodium pyrophosphate, 1mM β-glycerolphosphate, 1mM 
orthovanadate and 1 mM PMSF, supplemented with a protease inhibitor 
cocktail (P8340, Sigma-Aldrich). Following 30 min incubation at 4°C, 
samples were centrifuged at 18000x g, for 15 min. Total protein 
concentration in lysates was determined by the Bradford assay, using 
bovine albumin (Sigma) as standard. 
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2.12. Receptor recycling assay 
Cultured living hippocampal neurons (15 DIV), transfected with myc-
huGABAAR β3 (WT), were incubated at RT for 10 min in the presence of a 
high concentration of an anti-myc antibody (Cell Signaling). The myc-tag 
was located at the N-terminus of the β3 GABAAR subunits. The cells were 
then washed with PBS at 37°C to remove the unbound antibody and 
further incubated in an antibody free conditioned medium at 37°C for 20 
min allowing the internalization of antibody-bound receptors. The 
antibodies that remained on the cell surface were then stripped away by 
incubation in stripping buffer (0.5 M NaCl and 0.2 M acetic acid) on ice 
for 4 min (Passafaro et al., 2001). Neurons were then washed extensively 
with ice-cold PBS and returned back to culture medium at 37°C (for 
different periods of time) for recycling. After recycling, neurons were fixed, 
and Myc-antibody complexes recycling back to the surface were detected 
by incubation of the cells with a secondary antibody (anti-mouse IgG 
conjugated with Alexa Fluor 488). Neurons were then permeabilized, and 
intracellular Myc-antibody complexes were detected with a different 
secondary antibody (anti-mouse IgG conjugated with Alexa Fluor 568). 
The coverslips were then mounted on slides with a fluorescence 
mounting medium (DAKO). Images were acquired on Axio Observer 2.1 
fluorescence microscope (Zeiss) coupled to an Axiocam HRm digital 
camera and were quantified using the ImageJ image analysis software. 
For each experiment analyzed, the cells were stained and imaged using 
identical settings. The recycling of the receptors was calculated using a 
recycled antibody signal/total antibody signal ratio (Fig. 2.3). 
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FIGURE 2.3. Schematic representation of the receptor recycling assay. 
 
2.13. Co-immunoprecipitation assay 
After protein extraction and quantification, 5 μg of an anti-GABAAR β3 
subunit (NeuroMab) monoclonal antibody or anti-HAP1 (Santa Cruz 
Biotechnology) antibody were added to lysed samples (400 μg) and 
incubated overnight on a head-over-head shaker at 4°C in 1 ml of RIPA. 
Protein G Plus-Agarose beads (40 μl; Santa Cruz Biotechnology) were 
then added to lysis buffer and incubated for 2 h on a head-over-head 
shaker at 4°C. Beads were centrifuged at 800× g to remove the antibody, 
and the samples were then washed three times with lysis buffer and once 
with urea 1 M. Finally, beads were centrifuged at 800× g, the residual 
lysis buffer was removed and 50 μL of 2× loading buffer was added. 
Samples were heated at 90°C for 5 min and beads were centrifuged at 
800× g. The bead supernatants were used for western blot analysis. 
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2.14. Statistical analysis  
Statistical analysis was performed using one-way ANOVA analysis of 
variance, followed by the Dunnett’s or Bonferroni post-hoc test, or using 
the Student’s t test, as indicated in the figure captions. 
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3.1. OGD induces cell death and downregulates GABAAR 
subunit total protein levels by a calpain-dependent 
mechanism 
OGD is a well-established in vitro model of global cerebral ischemia 
(Dawson et al., 1996; Goldberg and Choi, 1993; Martin et al., 1994). 
Exposure of cultured hippocampal neurons to OGD for 60 min-120 min 
induced a time-dependent cell death, as determined by analysis of 
nuclear morphology 7 h or 12 h after the insult (Fig. 3.1). The short 
periods of OGD tested, 60 min or 75 min, induced ~20% cell death, while 
90 min or 120 min of OGD induced ~30% and ~40% cell death, 
respectively. We did not observe significant differences in cell death 
between the two post-incubation times used, 7 h and 12 h (p>0.05). 
 
 
 
FIGURE 3.1. OGD-induced neuronal death. 
Cultured hippocampal neurons (15 DIV) were subjected to OGD for the indicated 
periods of time (60 min, 75 min, 90 min and 120 min), and further incubated in 
culture-conditioned medium for 7 h or 12 h (post-incubation). Cell death was analyzed 
82 
after nuclei staining with Hoechst 33342. Representative results are shown in panel (A). 
Panel (B) shows the OGD-induced neuronal death, as calculated after subtracting 
neuronal death determined in preparations incubated under sham conditions for the 
same period of time. The results are average ± SEM of 3-5 different experiments 
performed in triplicate and in independent preparations. Statistical analysis was 
performed by one-way ANOVA, followed by Dunnett's test. *p<0.05, **p<0.01 - 
significantly different when compared to control conditions. 
 
To assess the effect of OGD on GABAAR subunit total protein levels, 
cultured hippocampal neurons were subjected to 90 min of OGD, and 
further incubated in culture conditioned medium for 8 h. GABAAR 
subunit protein levels were analyzed by western blot using specific 
antibodies against α1, α2, β3, γ2 and δ subunits. α1, α2, β3 and γ2 
subunits are localized preferentially at the synapse (Alldred et al., 2005; 
Nusser et al., 1998b), mediating phasic inhibition (Brickley et al., 1996), 
in contrast with δ subunits which are extrasynaptic (Nusser et al., 1998b). 
The results show a downregulation of all the synaptic GABAAR subunits, 
of ~40% for α1 subunits, ~20% for α2 subunits, and ~35% for β3 and γ2 
subunits (Fig. 3.2A-D), but no effect was observed for the δ subunit (Fig. 
3.2E). Shorter periods of OGD (60 min) did not affect GABAAR total 
protein levels (not shown). Similarly to the results obtained in 
hippocampal neurons subjected to OGD, a downregulation of α1, β3 and 
γ2 subunits was observed in the infarct core of mice subjected to 
transient MCAO, a model of focal brain ischemia, but no effect was 
observed for the δ subunit. No significant changes in GABAAR subunit 
protein levels were observed in the penumbra (Fig.3.3A). 
The OGD-induced [Ca2+]i overload activates calpains (Brorson et al., 
1995; Saido et al., 1994; Vanderklish and Bahr, 2000) which cleave 
numerous intracellular proteins in the ischemic brain (Bevers and 
Neumar, 2008). To investigate whether calpains are involved in the OGD-
induced downregulation of GABAAR subunits, hippocampal neurons were 
subjected to OGD in the presence or in the absence of the chemical 
inhibitors ALLN or MDL28170. Western blot analysis performed 8 h after 
injury showed that MDL28170 fully abrogated the effect of OGD on α1, 
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β3, α2 and γ2 GABAAR subunits (p>0.05) (Fig. 3.2A-E). Furthermore, 
ALLN clearly prevented the reduction of β3 and α2 subunits in 
hippocampal neurons subjected to OGD (Fig. 3.2B, C). 
 
 
 
FIGURE 3.2. α1, α2, β3 and γ2 GABAAR subunit protein levels are downregulated 
in in vitro ischemia (OGD) by a calpain-dependent mechanism. 
Cultured hippocampal neurons (15 DIV) were exposed to OGD for 90 min in the 
presence or in the absence of 50 μM ALLN and 50 μM MDL28170. α1 (A), β3 (B), α2 (C), 
and γ2 (D) GABAAR subunit total protein levels was determined by Western Blot 
analysis, 8 h after the insult, and the results were normalized with the loading control 
Synaptophysin. Results are the mean ± SEM of at least 3 independent experiments 
performed in different preparations, and are expressed as percentage of the control. 
Statistical analysis was performed by one-way ANOVA, followed by Dunnett's or 
Bonferroni test. *p<0.05, **p <0.01- significantly different when compared to control 
conditions, as depicted in the figure. 
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FIGURE 3.3. α1, β3 and γ2 GABAAR subunit protein levels are downregulated in 
transient brain ischemia in vivo (MCAO). 
(A) Effect of transient in vivo ischemia (MCAO) on α1, β3, γ2 and δ GABAAR subunit 
total protein levels, as determined 48 h after the lesion in the infarct core, penumbra 
and contralateral cortex. GABAAR subunit protein levels was determined by Western 
blot as indicated above. (B) Representative images of the regions dissected from the 
ipsilateral brain hemisphere of C57BL/6 mice subjected to sham surgery or MCAO, 
considered as infarct core (IC) and penumbra (delineated). Scale bar: 3mm. (B’) 
Representative image of the cerebral infarct core following a transient (45 min) occlusion 
of the MCA in C57BL/6 mice, as given by lack of TTC staining in contiguous 1 mm tick 
coronal slices (white). Scale bar, 3 mm. Results are the mean ± SEM of at least 3 
independent animals, and are expressed as percentage of the control. Statistical 
analysis was performed by one-way ANOVA, followed by Dunnett's or Bonferroni test. 
*p<0.05, **p <0.01 - significantly different from the contralateral region in sham 
operated animals; #p<0.05, ##p<0.01 - significantly different when compared to the 
corresponded region in sham operated animals, as depicted in the figure. N.S. - not 
significant 
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3.2. OGD downregulates the GABAAR subunit mRNA through 
activation of glutamate receptors 
The pool of protein in the cells is maintained by the balance between 
newly synthesized proteins and protein degradation. Considering the 
effect of OGD on the protein levels of GABAA receptor subunits (Figs. 3.2, 
3.3), we hypothesized that in vitro ischemia could also downregulate the 
mRNA for the various subunits causing a long-term effect on the 
synthesis of new receptors. Quantitative PCR experiments showed a 
decrease in the expression levels of α1, α2, β2, β3 and γ GABAAR 
subunits in hippocampal neurons subjected to OGD for 90 min, and 
further incubated in culture conditioned medium for 5 h, but no effect 
was observed for shorter periods of in vitro ischemia (75 min), even when 
determined 7 h after the insult (Fig. 3.4 A-E). The former experimental 
conditions led to a 70% reduction in mRNA levels of α1, 50% in α2 and 
β2, 25% in β3 and 40% in γ2 subunits, which are typically found in 
synaptic receptors. In contrast, no changes in the mRNA levels for the 
extrasynaptic GABAAR δ subunits was observed, even for 90 min of OGD 
(Fig. 3.4F). The OGD-induced downregulation of mRNA levels for α1, α2, 
β2, β3 and γ2 subunits was prevented by incubation with the NMDA and 
non-NMDA glutamate receptors inhibitors APV (100 μM) and NBQX (20 
μM) (Fig. 3.5).  
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FIGURE 3.4. OGD downregulates the mRNA levels of α1, α2, β3 and γ2 GABAARs 
subunits. 
Cultured hippocampal neurons (15 DIV) were exposed to OGD for 75 min or 90 min and 
further incubated for the indicated periods of time. The mRNA for α1 (A), α2 (C), β2 (D), 
β3 (B), γ2 (D) and δ (F) GABAAR subunits was determined by qPCR analysis. GAPDH 
and 18S ribosomal RNA were used as reference genes. Results are means ± SEM of at 
least 3 independent experiments, and expressed as percentage of control (sham). 
Statistical analysis was performed by one-way ANOVA, followed by Dunnett's test. 
*p<0.05, **p <0.01 - significantly different when compared to control conditions. 
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FIGURE 3.5. The effect of OGD on GABAAR mRNA levels is mediated by activation 
of glutamate receptors.  
Cultured hippocampal neurons were subjected to OGD (for 90 min) or incubated under 
control conditions (sham), in the presence or in the absence of the glutamate receptor 
inhibitors NBQX (20 μM) and APV (100 μM), as indicated, and further incubated in 
culture conditioned medium for 5 h. When the effect of glutamate receptor inhibitors 
was tested, the cells were pre-incubated with the drugs for 30 min, and were present 
during the period of OGD as well as during the subsequent incubation in culture 
conditioned medium. The mRNA levels for the α1 (A), α2 (C), β3 (B), β2 (D) and γ2 (E) 
GABAAR subunits was determined by qPCR. GAPDH and 18S ribosomal RNA were used 
as reference genes. (F) Neurons were subjected to OGD for the 90 min or incubated 
under control conditions (sham), in the presence or in the absence of the glutamate 
receptor inhibitors NBQX (20 μM) and APV (100 μM), as indicated, and further 
incubated in culture-conditioned medium for 5 h (post-incubation). Cell death was 
analyzed after nuclei staining with Hoechst 33342. Results are means ± SEM of at least 
3 independent experiments, and expressed as percentage of control (sham). Statistical 
analysis was performed by one-way ANOVA, followed by Dunnett's or Bonferroni test. 
*p<0.05, **p <0.01, #p<0.05, ##p<0.01 - significantly different when compared to control 
conditions or for the indicated comparisons. 
 
The results in Fig. 3.5F show a role for glutamate receptors in 
hippocampal neuronal death following OGD, as determined by nuclear 
morphology analysis. Although OGD decreased the mRNA levels for α1, 
α2, β2 and β3 subunits, inhibition of transcription is unlikely to 
contribute to the observed downregulation of GABAAR protein levels since 
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transcription blockage with actinomycin D for 9.5 h (the maximal 
duration of the OGD experiments) did not affect the abundance of α1, α2, 
β3 and γ2 protein levels (Fig. 3.6). 
 
FIGURE 3.6. Inhibition of transcription does not affect total protein levels of α1, 
α2, β3 and γ2 GABAAR subunits.  
Cultured hippocampal neurons (15 DIV) were incubated with Actinomycin D (1.5 μm) 
for 9.5 h, and α1 (A), α2 (C), β3 (B) and γ2 (D) GABAAR subunit total protein levels was 
determined by Western Blot analysis. The results were expressed as a percentage of the 
control, normalized with the loading control synaptophysin, and are the mean ± SEM of 
at least 3 independent experiments performed in different preparations. The differences 
obtained were not statistically significant, as determined by the Student's t test 
 
3.3. Downregulation of GABAAR α1 subunit/gephyrin 
interaction during OGD 
The number of GABAAR at the synapse determines the strength of 
inhibitory signaling. These receptors are very dynamic structures in the 
cell membrane, moving between synaptic and extrasynaptic sites 
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(Thomas et al., 2005), and their accumulation at the synapse is regulated 
by interaction with the scaffold protein gephyrin (Jacob et al., 2005). To 
evaluate if GABAAR/gephyrin interaction is altered in ischemic 
conditions, a surface co-immunoprecipitation protocol was used. 
Exposure of hippocampal neurons to OGD for 70 min, which does not 
affect total GABAAR α1 subunit protein levels (Fig. 3.7D), reduced by 
about 50% the interaction between surface-expressed receptor subunit 
and gephyrin (Fig. 3.7A, C), as demonstrated by immunoprecipitation of 
surface subunits followed by Western blot with an anti-gephyrin antibody 
(Fig. 3.7C). This effect was completely inhibited by cyclosporin A (1 µM), a 
calcineurin inhibitor, but was insensitive to okadaic acid (0.5 µM), an 
inhibitor of PP1α and PP2A phosphatases. 
Although okadaic acid did not affect the interaction between gephyrin 
and GABAAR α1 subunits, western blot experiments showed a shift of the 
band corresponding to gephyrin in extracts prepared from neurons 
incubated with okadaic acid (Fig. 3.7F). This shift did not correspond to 
an increase of total gephyrin protein levels, as confirmed by western blot 
quantification (Fig. 3.7E). To investigate whether the shift in the gephyrin 
band was due to phoshorylation of the scaffold protein, we performed the 
λ-phosphatase assay. Indeed, the observed shift in the gephyrin band 
was not observed when cell lysates were incubated with λ-phosphatase 
(Fig. 3.7F). Furthermore, no shift in gephyrin immunoreactivity was 
observed in extracts prepared from hippocampal neurons subjected to 
OGD, further suggesting that the phosphorylation sites regulated by 
protein phosphatases sensitive to okadaic acid are not involved in the 
regulation of the interaction between gephyrin and GABAAR α1 subunits. 
In contrast with the effect of phosphatase inhibitors on the OGD-induced 
downregulation of gephyrin/GABAAR α1 subunit interaction, the 
decrease in total surface expression of GABAAR α1 subunits under the 
same conditions was completely abrogated in the presence of okadaic 
acid (Fig. 3.7B and 3.7C), but was insensitive to cyclosporin A (1 µM). 
These results indicate that different protein phosphatases mediate the 
effect of OGD on the dissociation of GABAAR α1 subunits from gephyrin 
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and the decrease in surface expression GABAARs, presumably due an 
increase in the rate of internalization. 
 
 
 
FIGURE 3.7. OGD reduces the interaction of surface α1 GABAAR subunits with 
gephyrin. 
(A-C) A surface co-immunoprecipitation protocol was used to investigate the 
GABAAR/gephyrin interaction. Cultured hippocampal neurons were exposed to OGD for 
70 min and biotinylated as described in the methods section. Where indicated the cells 
were incubated with okadaic acid (0.5 μM) or with cyclosporin A (1 μM) during the OGD 
period. The surface GABAAR α1 subunits were analyzed by western blot with a specific 
antibody after purification with a surface co-immunoprecipitation assay (B). The co-
immunoprecipitation of gephyrin with the surface GABAAR α1 subunits was also 
analyzed by western blot with a specific antibody, and the ratio between gephyrin 
associated with surface GABAAR α1 and the plasma membrane associated GABAAR α1 
subunit is expressed in panel (A). A representative image is shown in panel (C). The 
effects of OGD on the total GABAAR α1 subunit and gephyrin protein levels were 
determined under the same experimental conditions (70 min of OGD) and the results 
are shown in panels (D) and (E) respectively. (F) Extracts prepared from cells treated 
under the indicated experimental conditions were incubated with 1 μl of λ-phosphatase 
(~20U/μl) for 60 min at 30°C before western blot analysis with an anti-gephyrin 
antibody. Results are means ± SEM of at least 3 independent experiments performed in 
different preparations, and expressed as percentage of the control. β-actin or GABAAR 
α1 were used as loading controls. Statistical analysis was performed by one-way 
ANOVA, followed by Dunnett's or Bonferroni test. *p<0.05, **p<0.01, #p<0.05 - 
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significantly different when compared to control conditions or for the indicated 
comparisons. 
 
3.4. OGD increases α1 GABAAR subunit internalization  
From the functional point of view, it is the population of GABAAR 
associated with the plasma membrane that is expected to play a role in 
the modulation of the demise process after OGD. To determine the rate at 
which the cell-surface GABAARs are internalized, we used an antibody 
feeding technique (Connolly et al., 1999; Lin et al., 2000) that allows 
distinguishing the cell-surface and the internalized pools of native 
GABAARs. Cell-surface GABAARs on living cultured hippocampal neurons 
were labeled with an anti-GABAAR-1 (N-terminus) antibody. 
Under resting conditions the GABAAR 1 subunit presented a constant 
rate of internalization for 30 min, when about 80% of the surface 
receptors were internalized. This rate of internalization, of about 10% of 
the surface receptors/10 min, was calculated both in the soma and 
neurites. In both compartments there was a pool of GABAAR 1 subunit, 
corresponding to about 20% of the labeled proteins, which was stable 
and did not undergo internalization during 60 min (Fig. 3.8A). Therefore, 
in all other experiments the internalization of GABAAR 1 subunits was 
followed for 10-20 min. 
The effect of OGD on GABAAR 1 subunit internalization was tested in 
hippocampal neurons subjected to the ischemic injury for 70 min, which 
does not affect the total protein levels of the receptor subunit (Fig. 3.7D). 
The experimental conditions used induce about 20% cell death as 
measured 7 h - 12 h after the insult (Fig. 3.1). Labeling of surface 
receptors was performed immediately after OGD, to capture the initial 
alterations in the mechanisms regulating receptor trafficking, and 
receptor internalization was measured for different periods of time (0-20 
min). Immunocytochemistry analysis revealed ~25% increase in the ratio 
of 1 subunit internalization compared to the corresponding sham 
condition, when tested for 20 min (Figs. 3.8B and 3.8C), both in the soma 
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and neurite compartments. This effect was abolished when 
internalization was blocked by a hyperosmolar concentration of sucrose 
(350 mM) (Figs. 3.8D and 3.8F), and with the specific dynamin inhibitor 
dynasor (125 µM) (Fig. 3.8E and 3.8G). Furthermore, the OGD-induced 
increase in the ratio of 1 subunit internalization was prevented by 
incubation with the NMDA and non-NMDA glutamate receptors inhibitors 
APV (100 μM) and NBQX (20 μM) (Fig. 3.9). 
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FIGURE 3.8. OGD increases α1 GABAAR subunit internalization by clathrin-
mediated endocytosis. 
Receptor internalization was assessed through an antibody-feeding assay and analyzed 
by fluorescence microscopy in cells labelled with an anti-GABAAR-1 (N-terminus) 
antibody. A time-course analysis of receptor internalization was performed in basal 
conditions (in culture conditioned medium) to validate the method (A). After 
quantification of the images at the soma and dendritic compartments, the results were 
expressed as a ratio of internalized receptors/total receptor immunoreactivity. Different 
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internalization periods were also tested in cells subjected to OGD (70 min) or 
maintained under control conditions (sham) before incubation with the anti-α1 GABAAR 
subunit antibody (B, C). Panels (D-G) show the effect of an hyperosmolar concentration 
of sucrose (350 mM) (D, F) and treatment with the dynamin inhibitor Dynasor (125 µM) 
(E, G) on the internalization of the α1 GABAAR subunit. Internalization of α1 GABAAR 
subunits was allowed for 20 min. When the effect of an hyperosmolar treatment was 
tested, the cells were incubated with 350 mM sucrose during the incubation period of 
surface receptor live staining and during the internalization period. The same strategy 
was adopted in the experiments with dynasor. Results are means  SEM of at least 3 
independent experiments, performed in different preparations. At least 10 cells were 
analysed for each experimental condition/experiment. Internalization ratio was 
calculated by the ratio internalized antibody signal/total antibody signal. Statistical 
analysis was performed by one-way ANOVA, followed by Dunnett's or Bonferroni test. 
*p<0.05, **p<0.01, ***p<0.001, ##p<0.01, ###p<0.001 - significantly different when 
compared to control conditions or for the indicated comparisons. 
 
 
 
FIGURE 3.9. Effect of OGD on GABAAR α1 subunit internalization is mediated by 
activation of glutamate receptors. 
Cultured hippocampal neurons were subjected to OGD (70 min) or maintained under 
control conditions (sham), and the internalization of GABAAR (20 min) was assessed 
through an antibody-feeding assay. When the effect of glutamate receptor antagonists 
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was tested, the cells were pre-incubated (or not) with NBQX (20 μM) and AP-5 (100 μM) 
for 30 min before OGD, and the inhibitors were also present during the whole 
experimental period. Representative fluorescence images are shown in panel (B) and the 
results in (A) are means  SEM of at least 3 different experiments performed in 
independent preparations. At least 10 cells were analysed in each condition per 
experiment. Ratio of internalization was calculated by internalized antibody signal/total 
antibody immunoreactivity. Statistical analysis was performed by one-way ANOVA, 
followed by Dunnett's or Bonferroni test. **p<0.01 - significantly different when 
compared to the sham condition. 
 
3.5. OGD-induced dephosphorylation of GABAAR β3 subunits 
leads to receptor internalization and mediates cell death 
The internalization of GABAAR is a process negatively regulated by 
phosphorylation of β3 or γ2 GABAAR subunit intracellular loop (Kittler et 
al., 2005; Kittler et al., 2008). The GABAAR β3 subunits are present in a 
large proportion of receptor subtypes in the hippocampus and cerebral 
cortex, regions that are particularly vulnerable to excitotoxicity (Lo et al., 
2003). To evaluate if the observed increase of GABAAR internalization 
(Fig. 3.8) is mediated by receptor dephosphorylation, the levels of 
GABAAR β3 subunit phosphorylation were evaluated by western blot 
analysis using a phospho-specific antibody against the β3 subunit serine 
residues 408/409 (mouse sequence) (Fig. 3.10). After 70 min of OGD, 
GABAAR β3 subunit phosphorylation was reduced by 60% (Fig. 3.10A, B), 
and a decrease in β3 subunit phosphorylation was also observed in the 
infarct core after transient MCAO (Fig. 3.10C, D). The effect of OGD on 
GABAAR β3 subunit phosphorylation level was reduced when the NMDA 
receptor inhibitor AP-5 (100 μM) was used (Fig. 3.10A). These 
observations are correlated with the role of NMDA receptors in OGD-
induced internalization of GABAAR α1 subunits (Fig. 3.9). Furthermore, 
the effect of OGD on β3 subunit dephosphorylation was prevented when 
neurons were incubated with 0.5 μM of okadaic acid (PP1/PP2A 
phosphatase inhibitor) but not in the presence of 1μM of cyclosporin A 
(calcineurin inhibitor) (Fig. 3.10B). 
In vitro studies showed that phosphorylation of GABAAR β3 subunit on 
serine residues 408/409 negatively regulates receptor endocytosis 
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(Terunuma et al., 2008). These two serine residues are located in an AP2-
binding motif conserved within the ICD of all GABAAR subunit isoforms 
(KTHLRRRSSQLK) (Kittler et al., 2005). To evaluate the role of β3 subunit 
dephosphorylation in the increase of GABAAR internalization during 
OGD, and its contribution to the excitotoxicity-induced neuronal death, 
we made phosphomutants of the GABAAR β3 subunit. Cultured 
hippocampal neurons (13 DIV) were transfected with the myc-tagged 
wild-type or the phospho-mimetic form (SS432/433DD) (homologous of 
mouse 408/409) of the huGABAARβ3 subunit, subjected to OGD for 90 
min and further incubated in culture conditioned medium for 12 h. The 
transfected cells were identified by immunocytochemistry with an anti-
myc antibody (as shown in Fig. 3.11B), and nuclear morphology analysis 
of transfected cells (Fig. 3.11A-B) showed a protective effect of the 
phospho-mimetic form of the receptor that reduced OGD-induced cell 
death by about 50% when compared with the wild-type β3 subunit. In 
contrast, non-transfected cells in the two types of cultures exhibited a 
similar rate of OGD-induced neuronal death (Fig. 3.11A’), showing the 
specificity of the effects resulting from the expression of the phospho-
mimetic form (SS432/433DD) of the huGABAAR β3 subunit. 
The surface expression of the mutant myc-tagged GABAAR β3 subunits 
was evaluated by immunocytochemistry with an anti-myc antibody under 
non-permeabilizing conditions (see Fig. 3.12A). The SS432/433DD 
mutant of the GABAAR β3 subunits presented an increased surface 
expression in transfected hippocampal neurons, both in control condition 
and after OGD (70 min), when compared to the WT GABAAR β3 subunits 
(Fig. 3.12B and B’). In contrast, transfection with the phospho-null 
mutant of GABAAR β3 subunits reduced the surface expression of the 
receptor, both in the somal (Fig. 3.12B) and neuritic compartments (Fig. 
3.12B’). The total expression of the myc-tagged wild-type, phospho-
mimetic and phospho-null (SS432/433AA) forms of the GABAAR β3 
subunit was evaluated by immunocytochemistry with an anti-myc 
antibody after permeabilization and showed a similar expression level of 
the three proteins (Fig. 3.12C-D’). The internalization rate of myc-tagged 
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wild type, phospho-mimetic and phospho-null GABAAR β3 (SS432/433) 
subunits, in cultured hippocampal neurons maintained under control 
conditions or subjected to OGD, was assessed using the antibody feeding 
technique (see Fig. 13A-B). A decrease in internalization ratio was 
observed for the phospho-mimetic mutant when compared with the WT 
GABAAR β3, in contrast with the phospho-null mutant which showed no 
alteration in internalization. Differential analysis of soma (Fig. 3.13A) and 
neurites (Fig. 3.13A’) showed similar results for the two cellular 
compartments. 
 
 
FIGURE 3.10. OGD decreases GABAAR β3 subunit dephosphorylation by a 
mechanism dependent on the activity of NMDAR and PP1/PP2A phosphatases. 
GABAAR β3 subunit phosphorylation was evaluated by western blot analysis using a 
phospho-specific antibody against the β3 subunit serine 408/409 (A, B). The cells were 
subjected to OGD (70 min) or maintained under control conditions (sham), and the 
following inhibitors were tested: APV (100 μM) (A), okadaic acid (0.5 μM) and 
cyclosporin A (1 μM) (B). When the effect of glutamate receptor antagonists was tested, 
the cells were pre-incubated with the drugs for 30 min and they were also present 
during the entire experiment. GABAAR β3 subunit phosphorylation was determined with 
98 
a specific antibody, which binds to the phosphorylated serine 408/409. (C-D) Effect of 
in vivo ischemia (MCAO) on β3 GABAAR subunit phosphorylation levels, as determined 
48 h after the lesion, in the infarct core, penumbra and contralateral cortex. GABAAR β3 
subunit phosphorylation was evaluated by Western blot, as indicated above. Results 
were normalized to the total protein levels of GABAAR β3 subunit or synaptophysin, and 
were expressed as percentage of control. The bars represent the means ± SEM of at least 
3 independent experiments performed in different preparations. Statistical analysis was 
performed by one-way ANOVA, followed by Dunnett's or Bonferroni test. **p<0.01, ***p 
<0.001, ###p<0.01 - significantly different when compared to control conditions. 
 
 
 
FIGURE 3.11. GABAAR β3 subunit dephosphorylation mediates OGD-induced cell 
death.  
(A-B) Cultured hippocampal neurons were transfected with the myc-tagged wild-type or 
the phospho-mimetic form (Ser408/409) of the GABAAR β3 subunit and subjected to 
OGD for 90 min before incubation in culture conditioned medium for 12 h. Where 
indicated (sham) the cells were treated under control conditions. The transfected cells 
were identified by immunocytochemistry with an anti-myc antibody, and the viability of 
transfected (A) and non-transfected (A’) cells was evaluated with Hoechst 33342. 
Representative images are shown in panel (B). The arrows point to the nuclei of 
hippocampal neurons transfected with the wild type or the phospho-mimetic forms of 
GABAAR β3 subunit. Under the same conditions, hippocampal neurons transfected with 
phospho-mimetic form of the GABAAR β3 subunit show a decrease in cell death (the 
arrow in the panel B points to the nuclei of transfected cells). For each experimental 
condition two coverslips were analyzed and at least 40 cells were counted per coverslip. 
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Results are means  SEM of at least 3 independent experiments, performed in different 
preparations. Statistical analysis was performed by one-way ANOVA, followed by 
Dunnett's or Bonferroni test. **p<0.01; ***p<0.001 - significantly different when 
compared to Sham condition. N.S. – not significant. 
 
 
 
FIGURE 3.12. OGD-induced GABAAR β3 subunit dephosphorylation decreases 
surface receptor protein levels.  
(A-B) Cultured hippocampal neurons were transfected with the myc-tagged wild-type, 
the phospho-mimetic form (Ser408/409) or the phospho-null GABAAR β3 (Ser432/433) 
form of the GABAAR β3 subunit and subjected to OGD for 70 min. Where indicated 
(sham) the cells were treated under control conditions. The effect of OGD on the surface 
expression of the myc-tagged GABAAR β3 subunits (phospho-mimetic and phospho-null 
forms) was evaluated by immunocytochemistry, in the somal (B) and neuritic 
compartments (B’), with an anti-myc antibody under non-permeabilizing conditions. 
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Representative images are shown in panel (C). The total expression of the myc-tagged 
wild-type, phospho-mimetic (SS432/433DD) and phospho-null (SS432/433AA) forms of 
the GABAAR β3 subunit was evaluated by immunocytochemistry with an anti-myc 
antibody after permeabilizing the cells (D and D’), and representative images are shown 
in panel (C). At least 10 cells were analysed in each condition per experiment. Results 
are means  SEM of at least 3 independent experiments, performed in different 
preparations. Statistical analysis was performed by one-way ANOVA, followed by 
Dunnett's or Bonferroni test. *p<0.05; **p<0.01; #p<0.05 - significantly different when 
compared to control conditions or for the indicated comparisons. N.S. – not significant.  
 
 
 
FIGURE 3.13. OGD-induced GABAAR β3 subunit dephosphorylation leads to 
receptor internalization.  
(A-C’) Cultured hippocampal neurons were transfected with the myc-tagged wild-type, 
the phospho-mimetic (Ser408/409) or the phospho-null GABAAR β3 (Ser432/433) form 
of the GABAAR β3 subunit and subjected to OGD for 70 min. Where indicated (sham) 
the cells were treated under control conditions. The rate of internalization of myc-tagged 
wild type, phospho-mimetic and phospho-null GABAAR β3 (Ser432/433) (homologous of 
mouse 408/409) subunits in cultured hippocampal neurons maintained under control 
conditions (sham) or subjected to OGD is shown in panels (A) and (A’). The 
internalization ratio, obtained by the antibody feeding assay, was calculated based on 
the immunoreactivity of the internalized antibody/total antibody signal. At least 10 cells 
were analysed in each condition per experiment. Results are means  SEM of at least 3 
independent experiments, performed in different preparations. Statistical analysis was 
performed by one-way ANOVA, followed by Dunnett's or Bonferroni test. *p<0.05 - 
significantly different when compared to sham condition. 
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3.6. OGD reduces GABAAR β3 subunits recycling and affects 
its interaction with HAP1 
Following internalization GABAAR are recycled back to the membrane or 
targeted to lysosomes for degradation (Kittler et al., 2004). To evaluate if 
the observed increase in GABAAR internalization (Figs. 3.8 and 3.13) is 
accompanied by an alteration in receptor recycling, the rate of GABAAR 
β3 subunit recycling was evaluated with a receptor recycling assay (Fig. 
3.14A-B). Cultured hippocampal neurons (13 DIV) were transfected with 
the myc-tagged wild-type GABAAR β3 subunit and the recycling rate was 
evaluated under control or OGD conditions. Labelling of surface 
receptors was performed immediately after OGD, and receptor 
internalization was allowed for 20 min (this incubation period allows the 
detection of the OGD-induced increase in the internalization of GABAAR 
α1 and β3 subunits [Figs. 3.8C-E and 3.13]) and the receptor recycling 
was measured at different periods of time (0-30 min). 
Immunocytochemistry analysis showed a ~15% decrease in the ratio of 
beta 3 subunit recycling compared to the correspondent sham condition 
when tested for 15 min and 30 min in the soma compartment (Figs. 
3.14B). In neurites this reduction corresponds to ~20% after 15 min 
(Figs. 3.14B) and ~25% when tested for 30 min.  
The sorting of GABAAR after the internalization is determined by the 
interaction of GABAAR with the HAP1 protein (Kittler et al., 2004). To 
evaluate if the GABAAR/HAP1 interaction is altered in ischemic 
conditions, a co-immunoprecipitation protocol was used. Exposure of 
hippocampal neurons to OGD for 70 min reduced by at least 30% the 
interaction between the surface-expressed GABAAR β3 subunit and HAP1 
(Fig. 3.14C, D), as demonstrated by immunoprecipitation of HAP1 
followed by western blot with a GABAAR β3 subunit antibody (Fig. 3.14C). 
The same result was obtained by immunoprecipitation of GABAAR β3 
subunits followed by western blot for HAP1 (Fig. 3.14D). These results 
indicate that OGD reduces GABAAR recycling possibly due to a decrease 
in the GABAAR/HAP1 interaction. 
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FIGURE 3.14. OGD decreases β3 GABAAR subunit interaction with HAP1 and 
GABAAR recycling. 
(A) Cultured hippocampal neurons were transfected with the myc-tagged wild-type β3 
GABAAR subunits. Receptor recycling was assessed through an antibody-feeding assay 
and analyzed by fluorescence microscopy in cells labelled with an anti-myc (N-terminus) 
antibody. Internalization of β3 GABAAR subunits was allowed for 20 min and recycling 
was measured for different periods of time (0, 15 and 30 min). (B) After quantification of 
the images somal and neuritic compartments, the results were expressed as a ratio of 
recycled receptors/total receptor immunoreactivity. (C-D) The co-immunoprecipitation 
protocol was used to determine GABAAR/HAP1 interaction. Cultured hippocampal 
neurons were exposed to OGD for 70 min and the immuneprecipitated HAP1 (C) or 
GABAAR β3 subunits (D) were analyzed by western blot with a specific antibody; the co-
immunoprecipitation of GABAAR or HAP1, respectively, was also analyzed by western 
blot with a specific antibody. The ratio between the co-immunoprecipitated protein 
levels and the immunoprecipitated protein was used for the quantification showed in 
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panels (C) and (D). Results are means  SEM of at least 3 independent experiments, 
performed in different preparations. At least 10 cells were analysed for each 
experimental condition/experiment. Recycling ratio was calculated by the ratio recycled 
antibody signal/total antibody signal. Statistical analysis was performed by one-way 
ANOVA, followed by Bonferroni test or Student's t test when appropriated. *p<0.05, 
**p<0.01, ***p<0.001 - significantly different when compared to control conditions. 
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Stroke, or cerebral ischemia, is characterized by an early disruption of 
GABAergic neurotransmission due to alterations at both pre- and post-
synaptic sides of the GABAergic synapse (Schwartz-Bloom and Sah, 
2001), but the molecular mechanisms involved are not fully understood. 
In this work we show a key role for protein phosphatases in the 
regulation of GABAAR α1 subunit interaction with gephyrin, an anchoring 
protein responsible for the receptor clustering at the synapse, and in the 
internalization of GABAAR in hippocampal neurons subjected to OGD, an 
in vitro model of global ischemia. In particular, the dephosphorylation of 
β3 GABAARs subunits was found to play a key role in receptor 
internalization following OGD and the resulting loss of inhibitory activity 
contributes to neuronal death. Moreover, we demonstrate that OGD 
reduces GABAAR recycling, probably by interfering with their interaction 
with the HAP1 protein. 
Using the antibody feeding assay we observed an increased 
internalization of GABAAR α1 and β3 subunits in hippocampal neurons 
subjected to OGD, in agreement with the evidence indicating that the 
majority of the receptors contain 2 α-, 2 β-, and 1 γ2-subunits (Rudolph 
and Mohler, 2004). The α1 GABAAR subunit is greatly expressed in the 
hippocampus (Hortnagl et al., 2013; Laurie et al., 1992; Wisden et al., 
1992), a brain region that is highly vulnerable to ischemic conditions 
(Kirino and Sano, 1984; Schmidt-Kastner and Freund, 1991; Sugawara 
et al., 1999). The OGD-induced internalization of GABAAR α1 subunits 
was mediated by clathrin-dependent endocytosis, sensitive to an 
hyperosmolar concentration of sucrose and to dynasor, and required 
glutamate receptor activation. A similar mechanism was shown to 
contribute to the internalization of GABAAR in an in vitro model of 
epilepsy, a condition also characterized by excitation/inhibition 
imbalance (Goodkin et al., 2005).  
GABAARs are clustered at the synapse through interaction with gephyrin 
(Tyagarajan and Fritschy, 2010), and the GABAAR α1 subunits were 
shown to interact directly with the scaffold protein (Mukherjee et al., 
2011; Tretter et al., 2011). This is in agreement with the results obtained 
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in the present study showing that surface GABAAR α1 subunits co-
immunoprecipitate with gephyrin. The interaction between the α1 
GABAAR subunit and gephyrin promotes the receptor accumulation at 
inhibitory synapses by limiting its lateral diffusion, and this interaction 
depends on residues 360–375 of the α1 subunit that bind directly to 
gephyrin (Mukherjee et al., 2011). Modulating this interaction via 
covalent modifications, such as phosphorylation, may be a potent 
mechanism to control the strength of fast GABAergic signaling. 
Accordingly, we observed that OGD significantly decreases the co-
immunoprecipitation of surface GABAAR α1 subunits with gephyrin by a 
mechanism sensitive to calcineurin inhibition. Since calcineurin had no 
effect on the apparent mobility of gephyrin in SDS-PAGE, the results 
suggest that the phosphatase may dephosphorylate GABAARs (Kapur and 
Lothman, 1990). There are indeed evidences showing that calcineurin 
activation mediates the effect of NMDA receptors in the reduction of 
GABA-mediated inhibition (Chen and Wong, 1995; Lu et al., 2000; Stelzer 
and Shi, 1994), but various mechanisms may be involved. Thus, the 
induction of long-term depression at CA1 inhibitory synapses resulted in 
a reduction in the synaptic GABAARs number by a calcineurin-dependent 
mechanism (Wang et al., 2003), while a direct effect of calcineurin on the 
functional properties of GABAARs was proposed in a different study 
(Jones and Westbrook, 1997). The effect of calcineurin on the 
dissociation of gephyrin-GABAAR α1 complexes induced by OGD clearly 
favors the former mechanism of action. However, at this point it is not 
possible to rule out an effect of OGD on the activity of protein kinase(s) 
responsible for the phosphorylation of the amino acid residues targeted 
by calcineurin (Chapell et al., 1998; Connolly et al., 1999; Filippova et 
al., 2000; Jovanovic et al., 2004).  
The possibility that gephyrin phosphorylation might regulate GABAAR 
binding to gephyrin, and their post-synaptic localization or trafficking, 
has not been investigated. Evidence available for glycine receptors (GlyR) 
demonstrate that proline-directed phosphorylation of gephyrin may 
induce a conformational change favoring GlyR binding (Tyagarajan and 
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Fritschy, 2010; Zita et al., 2007). Several studies identified gephyrin as a 
target for serine/threonine directed phosphorylation (Beausoleil et al., 
2006; Lundby et al., 2012), and a recent study detailed 18 different 
phosphorylation residues on gephyrin (Herweg and Schwarz, 2012), 
suggesting a key role for phosphorylation in the regulation of gephyrin 
function. Moreover, given that phosphorylation and intracellular Ca2+ rise 
make gephyrin susceptible to proteolysis by calpain (Tyagarajan et al., 
2013a) the neuronal activity-driven gephyrin dynamics could very likely 
be phosphorylation-dependent. Accordingly, gephyrin phosphorylation on 
Ser268 was recently shown to be important for scaling (up or down) 
GABAergic transmission (Tyagarajan et al., 2013a). 
In contrast with the role of calcineurin in OGD-induced dissociation of 
gephyrin – GABAAR α1 complexes, the dephosphorylation of GABAAR β3 
subunits under the same conditions is mediated by okadaic acid-
sensitive protein phosphatases (PP1 or PP2A). Recruitment of GABAAR 
into the endocytic pathway is facilitated via the interaction of the 
intracellular domains of β1–3 and γ2 subunits with μ2-AP2 (Kittler et al., 
2005; Kittler et al., 2008). This motif incorporates the major sites of 
phosphorylation by PKC and protein kinase A (PKA), corresponding to 
serine residues S408 and S409 in the case of the GABAAR β3 subunit 
(mouse sequence) (Brandon et al., 2002; McDonald and Moss, 1997). 
Phosphorylation of these sites has been shown to impair GABAAR 
endocytosis by preventing the interaction of the β3 subunit with AP2 
(Jacob et al., 2009; Kittler et al., 2005). The role of GABAAR β3 
dephosphorylation in receptor internalization and neuronal death in 
hippocampal neurons subjected to OGD is supported by the following 
evidences: i) OGD reduced the phosphorylation of GABAAR β3 subunit by 
a mechanism sensitive to okadaic acid, as determined by western blot 
with a phosphospecific antibody against serine residues 408/409; ii) the 
phospho-mimetic mutant of GABAAR β3 subunit (SS432/433AA) 
(homologous of mouse 408/409) was accumulated at cell surface and 
showed no OGD-induced internalization, and iii) the same mutation 
reduced significantly OGD-induced cell death. The neuroprotection 
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provided by the phospho-mimetic mutant of GABAAR β3 subunit, 
resulting from receptor activation by endogenous GABA, is highly 
remarkable considering that less than 10% of the cells present in the 
culture are GABAergic (Baptista et al., 2010). 
The triple arginine motif of the β3 GABAAR subunit that mediates direct 
binding of the receptor to the clathrin adaptor protein AP2 plays a key 
role in regulating the synaptic distribution of the receptor (Smith et al., 
2012). Furthermore, a peptide overlapping with the AP2 binding region in 
the β3 subunit, to compete the β3/AP2 interaction, was shown to 
decrease OGD-induced cell death, in agreement with the results obtained 
in this work using a distinct experimental approach. However, the use of 
a peptide overlapping with the AP2 binding region in the β3 subunit does 
not rule out non-specific effects on the internalization of other plasma 
membrane proteins, which may also interact with AP2 on the same 
binding motif.  
GABAAR cell surface stability is determined not only by their 
internalization ratio but also by the post-internalization sorting 
mechanisms. Upon internalization GABAARs are rapidly recycled back to 
the cell surface, whereas over longer periods of internalization the 
receptors are also targeted for lysosomal degradation (Kittler et al., 2004). 
HAP1 plays a key role in these processes since it directly binds to 
GABAAR, thereby preventing their degradation and enhancing receptor 
recycling to the plasma membrane (Kittler et al., 2004). We showed that 
OGD downregulates GABAAR recycling, possibly due to a reduction in the 
interaction of the receptor with HAP1, as suggested by the co-
immunoprecipitation assay. These observations are relevant to 
understand the down-modulation of GABAAR surface expression not only 
in brain ischemia but also in pathological conditions such as epilepsy, in 
which an acute reduction in receptor surface expression and loss of 
synaptic GABAAR leads to a compromised neuronal inhibition and altered 
excitability states (Mielke and Wang, 2005; Naylor et al., 2005; Tan et al., 
2007). However, the mechanisms involved in the downregulation of 
GABAAR under the latter conditions remain unclear. 
 111 
CHAPTER 4 – Discussion 
In addition to the effect on the surface expression of GABAARs, OGD also 
downregulated the total protein levels (α1, α2, β3 and γ2 subunits) and 
mRNA (α1, α2, β2, β3 and γ2 subunits) for GABAAR subunits, which is 
likely to have a delayed and long-lasting effect on GABAergic synaptic 
transmission. At least some of the effects of OGD on GABAAR subunits 
(e.g. α2 and β3) are mediated by calpains. The upregulation of calpain 
activity under excitotoxic conditions and in brain ischemia is also 
coupled to an abnormal cleavage and/or degradation of several other 
proteins (Gomes et al., 2012; Gomes et al., 2011; Lobo et al., 2011), 
thereby contributing to neural death. The OGD-induced downregulation 
of the mRNA levels for α1, α2, β2, β3 and γ2 GABAA receptor subunits 
was mediated by activation of glutamate receptors and would prevent the 
replenishment of the GABAA receptor pool degraded in response to the 
injury. Interestingly, under the OGD conditions used the mRNA levels for 
the GABAAR δ subunit were not significantly altered. Considering that 
this subunit is found at extrasynaptic regions (Nusser et al., 1998b), the 
results suggest that OGD has differential effects on the synaptic and 
extrasynaptic pools of GABAARs. 
In conclusion, we showed that (de)phosphorylation of GABAAR β3 
subunits on serines 408/409 (mouse sequence) is a master regulator of 
GABAAR surface localization in ischemic conditions, and receptor 
internalization, together with a reduction in the rate of recycling, 
contributes to the death of hippocampal neurons after transient OGD. 
Recruitment of GABAAR for internalization is induced by glutamate 
receptor activation and follows the impairment in their interaction with 
the scaffold protein gephyrin, by a mechanism that is also regulated by 
protein phosphatases (Fig. 4.1). The degradation of GABAARs and the 
downregulation of their mRNAs may further reduce GABAergic synaptic 
transmission. Taken together, these results suggest that modulation of 
GABAAR phosphorylation might be a therapeutic target to preserve 
synaptic inhibition in brain ischemia. 
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FIGURE 4.1. Model of GABAAR internalization during cerebral ischemia.  
Ischemic insult (1) overactivates NMDAR signalling (2) and the resulting activation of 
calcineurin decreases GABAAR/Gephyrin interaction (3). In parallel, OGD reduces 
phosphorylation of GABAAR β3 subunit by a mechanism sensitive to okadaic acid (4), 
inducing the internalization of GABAAR via clathrin dependent endocytosis (5, 6). OGD 
also reduce GABAAR/HAP1 interaction and GABAAR recycling rate (7, 8), driving 
GABAAR to degradation. 
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